Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the United Kingdom and Ireland: What is new?

Bassareo PP.

Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms

Yaron JR, Zhang L, Guo Q, Haydel SE, Lucas AR.

Vascular Inflammation as a Therapeutic Target in COVID-19 "Long Haulers": HIITing the Spot?

Christensen RH, Berg RMG.

MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-κB Pathway

Chen B, Han J, Chen S, Xie R, Yang J, Zhou T, Zhang Q, Xia R.

The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C)

Mavrogeni SI, Kolovou G, Tsirimpis V, Kafetzis D, Tsolas G, Fotis L.

Effects of simulated COVID-19 cytokine storm on stent thrombogenicity

Cornelissen A, Kutyna M, Cheng Q, Sato Y, Kawakami R, Sakamoto A, Kawai K, Mori M, Fernandez R, Guo L, Pellegrini D, Guagliumi G, Barakat M, Virmani R, Finn A.

[Recommendation for the recognition, management and follow up of cardiovascular compromise in patients with Pediatric Multisystemic Inflammatory Syndrome associated with COVID-19 (PIMS-CT). Position statement of Chilean Scientific Societies]

Álvarez Z P, Larios G G, Toro R L, Acevedo A V, Arancibia G F, Cárdenas M L, Fernández C C.

Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone

Olajide OA, Iwuanyanwu VU, Lepiarz-Raba I, Al-Hindawi AA.

High dimensional cytokine panels reveal common SARS-CoV-2-related inflammation patterns across different latitudes

Palma P.

Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response

Mithal A, Hume AJ, Lindstrom-Vautrin J, Villacorta-Martin C, Olejnik J, Bullitt E, Hinds A, Mühlberger E, Mostoslavsky G.

Subtle microvascular endothelial impairment in a young patient after mild COVID-19 illness

Hellmann M, Romanowska-Kocejko M, Żarczyńska-Buchowiecka M, Dudziak M.

Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review

Banji D, Alqahtani SS, Banji OJF, Machanchery S, Shoaib A.

Management of COVID-19-associated multisystem inflammatory syndrome in children: A comprehensive literature review

Kiss A, Ryan PM, Mondal T.

Is IL-6 a key cytokine target for therapy in COVID-19?

Jones SA, Hunter CA.

Pattern of inflammatory immune response determines the clinical course and outcome of COVID-19: unbiased clustering analysis

Lee EE, Song KH, Hwang W, Ham SY, Jeong H, Kim JH, Oh HS, Kang YM, Lee EB, Kim NJ, Chin BS, Park JK.

Systemic Inflammation Is Associated With Neurologic Involvement in Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2

Sa M, Mirza L, Carter M, Carlton Jones L, Gowda V, Handforth J, Hedderly T, Kenny J, Lascelles K, Lin JP, Lumsden D, McDougall M, Miller O, Rossor T, Shivamurthy V, Siddiqui A, Singh R, Tang S, White M, Byrne S, Lim M; Evelina PIMS-TS Study Group.

Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era

Valitutti F, Verde A, Pepe A, Sorrentino E, Veneruso D, Ranucci G, Orlando F, Mastrominico A, Grella MG, Mandato C.

Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm

Kim H, Lee HS, Ahn JH, Hong KS, Jang JG, An J, Mun YH, Yoo SY, Choi YJ, Yun MY, Song GY, Joo J, Na DH, Kim HN, Park HH, Lee JY, Lee W.

Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial

Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, Willicombe M, Pilay C, Shturova T, Almonte M, Charania A, Turner R, Kon OM, Cooke G, Thursz M, Cherlin S, Wason J, Milojkovic D, Innes AJ, Cooper N.

[Anti-inflammatory therapies for SARS-COV2 infection from a hematological perspective]

Rojas P, Sarmiento M.

[SARS-CoV-2 infection as a thrombo-inflammatory endothelial disease]

Samaniego F, Conte G.

SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children (MIS-C)

Kouo T, Chaisawangwong W.

Paediatric multisystem inflammatory syndrome and COVID-19: another novel syndrome?

Leung KKY, Hon KL, Wang MHT, Ng DKK, Ip P.

Weathering the storm: COVID-19 infection in patients with hematological malignancies

Wang LQ, Tan Su Yin E, Wei GQ, Hu YX, Nagler A, Huang H.

COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)

Pfaar O, Klimek L, Hamelmann E, Kleine-Tebbe J, Taube C, Wagenmann M, Werfel T, Brehler R, Novak N, Mülleneisen N, Becker S, Worm M.

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome

Caldarale F, Giacomelli M, Garrafa E, Tamassia N, Morreale A, Poli P, Timpano S, Baresi G, Zunica F, Cattalini M, Moratto D, Chiarini M, Cannizzo ES, Marchetti G, Cassatella MA, Taddio A, Tommasini A, Badolato R.

COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire

Seddiki N, French M.

Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases

Elashiry M, Elsayed R, Elashiry MM, Rashid MH, Ara R, Arbab AS, Elawady AR, Hamrick M, Liu Y, Zhi W, Lucas R, Vazquez J, Cutler CW.

COVID-19-related multisystem inflammatory syndrome in children: The plot thickens!

Kohli JK, Magoon R, ItiShri, Kashav R.

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study

Young BE, Wei WE, Fong SW, Mak TM, Anderson DE, Chan YH, Pung R, Heng CS, Ang LW, Zheng AKE, Lee B, Kalimuddin S, Pada S, Tambyah PA, Parthasarathy P, Tan SY, Sun L, Smith GJ, Lin RTP, Leo YS, Renia L, Wang LF, Ng LF, Maurer-Stroh S, Lye DC, Lee VJ.

Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity

Tang Y, Sun J, Pan H, Yao F, Yuan Y, Zeng M, Ye G, Yang G, Zheng B, Fan J, Pan Y, Zhao Z, Guo S, Liu Y, Liao F, Duan Y, Jiao X, Li Y.

Successful hemostasis of bleeding gastric inflammatory fibroid polyp by endoscopic treatment in a patient with severe COVID-19

Murota A, Yoshi S, Okuda R, Oowada S, Yamakawa T, Kazama T, Hirayama D, Ishigami K, Yamano HO, Narimatu E, Sugita S, Hasegawa T, Nakase H.

Multisystem Inflammatory Syndrome in an Adult

Amato MK, Hennessy C, Shah K, Mayer J.

A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm

Pouladzadeh M, Safdarian M, Eshghi P, Abolghasemi H, Bavani AG, Sheibani B, Moradi Choghakabodi P, Feghhi A, Ghafourian Boroujerdnia M, Forouzan A, Jalali Far MA, Kaydani GA, Rajaei E, Amin M, Torabizadeh M, Yousefi F, Hadaddezfuli R.

Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection

Lopez-Castaneda S, García-Larragoiti N, Cano-Mendez A, Blancas-Ayala K, Damian-Vázquez G, Perez-Medina AI, Chora-Hernández LD, Arean-Martínez C, Viveros-Sandoval ME.

Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis

Read SA, Gloss BS, Liddle C, George J, Ahlenstiel G.

Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19

Xie C, Li Q, Li L, Peng X, Ling Z, Xiao B, Feng J, Chen Z, Chang D, Xie L, Dela Cruz CS, Sharma L.

Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection

Shrivastava R, Shrivastava R, Johansen B, Allain T.

The role of chest CT quantitative pulmonary inflammatory index in the evaluation of the course and treatment outcome of COVID-19 pneumonia

Peng S, Chen J, Zhang W, Zhang B, Liu Z, Liu L, Wu Z, Fu R, Li X, Lv F.

Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic

Viola A, Giambò F, Chiappetta MF, Costantino G, Pallio S, Fries W.

A mechanism for matrikine regulation in acute inflammatory lung injury

Robison SW, Li J, Viera L, Blackburn JP, Patel RP, Blalock JE, Gaggar A, Xu X.

Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey

Queiroz NSF, Teixeira FV, Motta MP, Chebli LA, Hino AAF, Martins CA, Quaresma AB, da Silva AAP, Damião AOMC, Saad-Hossne R, Kotze PG.

Carotid Artery Dissection and Hemorrhagic Stroke in the Setting of Multisystem Inflammatory Syndrome in Children

Salik I, Jacoby M.

The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients

Gaspar P, Parreira I, Antunes Meireles P, Bessa F, Dias Silva V, Abrantes AM, Pais de Lacerda A, Mota C.

Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions

Gheware A, Dholakia D, Kannan S, Panda L, Rani R, Pattnaik BR, Jain V, Parekh Y, Enayathullah MG, Bokara KK, Subramanian V, Mukerji M, Agrawal A, Prasher B.

A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling

Li S, Jiang L, Beckmann K, Højen JF, Pessara U, Powers NE, de Graaf DM, Azam T, Lindenberger J, Eisenmesser EZ, Fischer S, Dinarello CA.

Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection

Welcome MO, Mastorakis NE.

Inflammatory profiles and clinical features of COVID-19 survivors three months after discharge in Wuhan, China

Zhou M, Yin Z, Xu J, Wang S, Liao T, Wang K, Li Y, Yang F, Wang Z, Yang G, Zhang J, Yang J.

Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19

Landmesser U, Lehmann I, Eils R.

Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic

Belay ED, Abrams J, Oster ME, Giovanni J, Pierce T, Meng L, Prezzato E, Balachandran N, Openshaw JJ, Rosen HE, Kim M, Richardson G, Hand J, Tobin-D'Angelo M, Wilson S, Hartley A, Jones C, Kolsin J, Mohamed H, Colles Z, Hammett T, Patel P, Stierman B, Campbell AP, Godfred-Cato S.

Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan

Yamada Y, Fujinami K, Eguchi T, Takefuji H, Mori N.

Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel Disease

Botwin GJ, Li D, Figueiredo J, Cheng S, Braun J, McGovern DPB, Melmed GY.

LncRNAs NEAT1 and MALAT1 Differentiate Inflammation in Severe COVID-19 Patients

Huang K, Wang C, Vagts C, Raguveer V, Finn PW, Perkins DL.

Care of inflammatory bowel disease patients during coronavirus disease-19 pandemic using digital health-care technology

Ghoshal UC, Sahu S, Biswas SN, Singh P, Chaudhary M, Ghoshal U, Tiwari P, Rai S, Mishra SK.

Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients

Perna F, Bruzzaniti S, Piemonte E, Maddaloni V, Atripaldi L, Sale S, Sanduzzi A, Nicastro C, Pepe N, Bifulco M, Matarese G, Galgani M, Atripaldi L.

The influenza season during COVID-19 pandemic: The storm that never came

Elsaddig M, Kalafat E, O'Brien P, Khalil A.

Immunomodulatory and anti-inflammatory potential of crocin in COVID-19 treatment

Ghasemnejad-Berenji M.

Anti-Inflammatory treatment of COVID-19 pneumonia with tofacitinib alone or in combination with dexamethasone is safe and possibly superior to dexamethasone as a single agent in a predominantly African American cohort

Hayek ME, Mansour M, Ndetan H, Burkes Q, Corkren R, Dulli A, Hayek R, Parvez K, Singh S.

Echocardiographic clues in diagnosis of Takayasu arteritis in a child with SARS-CoV-2 related Multisystem Inflammatory Syndrome

Qasim A, Kaushal S, Bansal M, Lasa JJ, Sanchez Mejia AA.

Critical Illness and Systemic Inflammation Are Key Risk Factors of Severe Acute Kidney Injury in Patients With COVID-19

Hardenberg JB, Stockmann H, Aigner A, Gotthardt I, Enghard P, Hinze C, Balzer F, Schmidt D, Zickler D, Kruse J, Körner R, Stegemann M, Schneider T, Schumann M, Müller-Redetzky H, Angermair S, Budde K, Weber-Carstens S, Witzenrath M, Treskatsch S, Siegmund B, Spies C, Suttorp N, Rauch G, Eckardt KU, Schmidt-Ott KM.

Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries

Suzuki J, Abe K, Matsui T, Honda T, Yasukawa K, Takanashi JI, Hamada H.

Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019

Zhang W, Li C, Xu Y, He B, Hu M, Cao G, Li L, Wu S, Wang X, Zhang C, Zhao J, Xie J, Xu Z, Li Q, Wang G.

Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome

Michotte N, Allard S, Payen MC, Dauby N.

Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway

Zhang Y, Wang R, Shi W, Zhihui Z, Wang X, Li C, Zhang S, Zhang P.

Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Wong Chung JERE, Engin Ö, Wolfs TFW, Renson TJC, de Boer JH.

Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark

Kjeldsen J, Nielsen J, Ellingsen T, Knudsen T, Nielsen RG, Larsen MD, Lund K, Nørgård BM.

The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective, multicenter, descriptive study from Wuhan, China

Xiang H, Song B, Zhang Y, Zhang J, Xiong J.

Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial

Yousefi M, Sadriirani M, PourMahmoudi A, Mahmoodi S, Samimi B, Hosseinikia M, Saeedinezhad Z, Panahande SB.

The Inflammatory Profile of Obesity and the Role on Pulmonary Bacterial and Viral Infections

Hornung F, Rogal J, Loskill P, Löffler B, Deinhardt-Emmer S.

Comparative Investigation of Composition, Antifungal, and Anti-Inflammatory Effects of the Essential Oil from Three Industrial Hemp Varieties from Italian Cultivation

Orlando G, Adorisio S, Delfino D, Chiavaroli A, Brunetti L, Recinella L, Leone S, D'Antonio M, Zengin G, Acquaviva A, Antico M, Angelini P, Angeles Flores G, Venanzoni R, Tacchini M, Di Simone SC, Menghini L, Ferrante C.

Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with COVID-19: A Randomized Trial

Esposito P, Cipriani L, Verzola D, Grignano MA, De Amici M, Testa G, Grosjean F, Russo E, Garibotto G, Rampino T, Viazzi F.

Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes

Feng E, Balint E, Poznanski SM, Ashkar AA, Loeb M.

Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns

Martínez-Botía P, Bernardo Á, Acebes-Huerta A, Caro A, Leoz B, Martínez-Carballeira D, Palomo-Antequera C, Soto I, Gutiérrez L.

Potential Therapeutic Applications of Hydrogen in Chronic Inflammatory Diseases: Possible Inhibiting Role on Mitochondrial Stress

Hirano SI, Ichikawa Y, Sato B, Yamamoto H, Takefuji Y, Satoh F.

Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ

Sur S, Khatun M, Steele R, Isbell TS, Ray R, Ray RB.

Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence

Pelaia C, Calabrese C, Garofalo E, Bruni A, Vatrella A, Pelaia G.

SARS-CoV-2 Infection and Inflammatory Response in a Twin Pregnancy

Trombetta A, Comar M, Tommasini A, Canton M, Campisciano G, Zanotta N, Cason C, Maso G, Risso FM.

Link between Viral Infections, Immune System, Inflammation and Diet

Suardi C, Cazzaniga E, Graci S, Dongo D, Palestini P.

Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis

Hardy E, Fernandez-Patron C.

Development of an In Vitro Airway Epithelial-Endothelial Cell Culture Model on a Flexible Porous Poly(Trimethylene Carbonate) Membrane Based on Calu-3 Airway Epithelial Cells and Lung Microvascular Endothelial Cells

Pasman T, Baptista D, van Riet S, Truckenmüller RK, Hiemstra PS, Rottier RJ, Hamelmann NM, Paulusse JMJ, Stamatialis D, Poot AA.

Severe Intraocular Inflammation following Hydrophilic Acrylic Phakic Intraocular Lens Implantation in A Case with Concealed History of COVID-19: A Case Report and Literature Review

Toprak I, Cetin EN, Gunes CE, Martin-Seker C.

Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19) Infection: Possible role for the NLRP3 inflammasome

Paul O, Tao JQ, Litzky L, Feldman M, Montone K, Rajapakse C, Bermudez C, Chatterjee S.

Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment

Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, Liu Y, Yu H, Pieper AA, Jehi L, Cheng F.

White Button Mushroom (Agaricus bisporus) Interrupts Tissue AR-TMPRSS2 Expression and Attenuates Pro-inflammatory Cytokines in C57BL/6 Mice: Implication for COVID-19 Dietary Intervention

Chen S, Wang X, Ha D, Yoshitake R.

SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?

Chattopadhyay I, Shankar EM.

Dooming Phagocyte Responses: Inflammatory Effects of Endogenous Oxidized Phospholipids

Di Gioia M, Zanoni I.

Sixth nerve palsy in pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection

Hernandez-Garcia E, Arriola-Villalobos P, Burgos-Blasco B, Morales-Fernandez L, Gomez-de-Liaño R.

The association between vitamin D levels and the clinical severity and inflammation markers in pediatric COVID-19 patients: single-center experience from a pandemic hospital

Bayramoğlu E, Akkoç G, Ağbaş A, Akgün Ö, Yurdakul K, Selçuk Duru HN, Elevli M.

Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome

Gupta A, Gill A.

Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19

Alikhani M, Javadi A, Aalikhani M.

Cytokine profiling in Iranian patients with COVID-19; association with clinical severity

Taghiloo S, Soltanshahi M, Aliyali M, Abedi S, Mehravaran H, Ajami A, Asgarian-Omran H.

High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection

Cappellano G, Abreu H, Raineri D, Scotti L, Castello L, Vaschetto R, Chiocchetti A.

Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2

Gour A, Manhas D, Bag S, Gorain B, Nandi U.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Marotte H, Servettaz A, Domont F, Chazerain P, Devaux M, Claudepierre P, Langlois V, Mekinian A, Maria ATJ, Banneville B, Fautrel B, Pouchot J, Thomas T, Flipo RM, Richez C; FAI2R/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors.

Potential New Treatments for Kawasaki Disease, Its Variations, and Multisystem Inflammatory Syndrome

Roe K.

Ultraefficiently Calming Cytokine Storm Using Ti(3)C(2)T (x) MXene

Wang T, Sun X, Guo X, Zhang J, Yang J, Tao S, Guan J, Zhou L, Han J, Wang C, Yao H, Wang G.

Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19

Sánchez-Oro R, Fatahi Bandpey ML, García Martínez E, Edo Prades MÁ, Alonso Muñoz EM.

Low risk of severe COVID‑19 in patients with inflammatory bowel disease: keep calm and take stock

Allocca M, Craviotto V.

COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology

Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, Lee MS, Hong SJ, Choi BY, Lee SS, Back HJ; Korean College of Rheumatology Task Force for COVID-19 Vaccine Guidance for Patients with Autoimmune Inflammatory Rheumatic Diseases.

Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome

Diakite S, Bousdira N, Tachon G, Ackermann F, Groh M, Rohmer J.

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation - Authors' reply

Cavalli G, Larcher A, Tomelleri A, Dagna L.

Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy

Pensato U, Muccioli L, Cani I, Janigro D, Zinzani PL, Guarino M, Cortelli P, Bisulli F.

A Novel Large-Vessel Arteritis in SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Children (MIS-C)

Salman R, Masand P, Huisman TAGM, Pereira M, Kearney DL, Guillerman RP, Jadhav S.

Thoracic Imaging Findings of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: What Radiologists Need to Know Now

Winant AJ, Blumfield E, Liszewski MC, Kurian J, Foust AM, Lee EY.

Severe COVID-19 Pneumonia: Assessing Inflammation Burden with Volume-rendered Chest CT

Tang L, Zhang X, Wang Y, Zeng X.

Ethyl Pyruvate as a Potential Defense Intervention against Cytokine Storm in COVID-19?

Tanwar O, Soni A, Prajapat P, Shivhare T, Pandey P, Samaiya PK, Pandey SP, Kar P.

Development of symptomatic inflammatory aneurysm treated with endovascular repair in COVID-19 infected patient

Riley CJ, Teixeira P.

The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis

Mahat RK, Panda S, Rathore V, Swain S, Yadav L, Sah SP.

Cardiac abnormalities due to multisystem inflammatory syndrome temporally associated with Covid-19 among children: A systematic review and meta-analysis

Haghighi Aski B, Manafi Anari A, Abolhasan Choobdar F, Zareh Mahmoudabadi R, Sakhaie M.

Cutaneous Findings in SARS-CoV-2-Associated Multisystem Inflammatory Disease in Children

Blatz AM, Oboite M, Chiotos K, Castelo-Soccio L, Odom John AR; Children’s Hospital of Philadelphia MIS-C Research Collaborative.

SARS-CoV-2, recurrent ischemic strokes and carotid macrothrombosis: the other face of the cytokine storm (a case report)

Aasfara J, Jidane S, Laarje A, Yamani KE, Belyamani L, Tijani Y.

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody

Gebremeskel S, Schanin J, Coyle KM, Butuci M, Luu T, Brock EC, Xu A, Wong A, Leung J, Korver W, Morin RD, Schleimer RP, Bochner BS, Youngblood BA.

Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia

Zingaropoli MA, Nijhawan P, Carraro A, Pasculli P, Zuccalà P, Perri V, Marocco R, Kertusha B, Siccardi G, Del Borgo C, Curtolo A, Ajassa C, Iannetta M, Ciardi MR, Mastroianni CM, Lichtner M.

The Good Treatment, the Bad Virus, and the Ugly Inflammation: Pathophysiology of Kidney Involvement During COVID-19

Le Stang MB, Desenclos J, Flamant M, Chousterman BG, Tabibzadeh N.

How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician

Chebli JMF, Queiroz NSF, Damião AOMC, Chebli LA, Costa MHM, Parra RS.

Diabetes, inflammation, and the adiponectin paradox: therapeutic targets in SARS-CoV-2

Ho G, Ali A, Takamatsu Y, Wada R, Masliah E, Hashimoto M.

Assessing inflammatory status in COVID-19: a role in the pandemic?

Corica B, Romiti GF.

Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic

Moum KM, Moum B, Opheim R.

Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series

Kaya Tutar N, Omerhoca S, Coban E, Kale N.

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients

Contoli M, Papi A, Tomassetti L, Rizzo P, Vieceli Dalla Sega F, Fortini F, Torsani F, Morandi L, Ronzoni L, Zucchetti O, Pavasini R, Fogagnolo A, Volta CA, Bartlett NW, Johnston SL, Spadaro S, Campo G.

The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection

Nobile B, Durand M, Olié E, Guillaume S, Molès JP, Haffen E, Courtet P.

The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm

Zimecki M, Actor JK, Kruzel ML.

Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19

Szabo PA, Dogra P, Gray JI, Wells SB, Connors TJ, Weisberg SP, Krupska I, Matsumoto R, Poon MML, Idzikowski E, Morris SE, Pasin C, Yates AJ, Ku A, Chait M, Davis-Porada J, Guo XV, Zhou J, Steinle M, Mackay S, Saqi A, Baldwin MR, Sims PA, Farber DL.

Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations

Bekic D, Belosic Halle Z.

Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C)

Feketea G, Vlacha V, Bocsan IC, Vassilopoulou E, Stanciu LA, Zdrenghea M.

Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients

Li Y, Jiang Y, Zhang Y, Li N, Yin Q, Liu L, Lv X, Liu Y, Li A, Fang B, Li J, Ye H, Yang G, Cui X, Liu Y, Qu Y, Li C, Li J, Li D, Gai Z, Wang S, Zhan F, Liang M.

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Geisen UM, Berner DK, Tran F, Sümbül M, Vullriede L, Ciripoi M, Reid HM, Schaffarzyk A, Longardt AC, Franzenburg J, Hoff P, Schirmer JH, Zeuner R, Friedrichs A, Steinbach A, Knies C, Markewitz RD, Morrison PJ, Gerdes S, Schreiber S, Hoyer BF.

The Calm Before the Storm: Utilizing In Situ Simulation to Evaluate for Preparedness of an Alternative Care Hospital During COVID-19 Pandemic

Petrone G, Brown L, Binder W, Naganathan S, Pasichow S, Rybasack-Smith H, Duquette CE, Palka DR, Musits AN.

Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS

Jouan Y, Baranek T, Si-Tahar M, Paget C, Guillon A.

Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020

Niño-Taravilla C, Otaola-Arca H, Lara-Aguilera N, Zuleta-Morales Y, Ortiz-Fritz P.

Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection

Meanwatthana J, Majam T.

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?

Honore PM, Redant S, De Bels D.

SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release

Junqueira C, Crespo Â, Ranjbar S, Ingber J, Parry B, Ravid S, de Lacerda LB, Lewandrowski M, Clark S, Ho F, Vora SM, Leger V, Beakes C, Margolin J, Russell N, Gehrke L, Adhikari UD, Henderson L, Janssen E, Kwon D, Sander C, Abraham J, Filbin M, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Lieberman J.

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway

Khan S, Shafiei MS, Longoria C, Schoggins J, Savani RC, Zaki H.

The Covid-19 pandemic: a veritable storm of ethical tensions

Charlier P.

Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction

Balkrishna A, Haldar S, Singh H, Roy P, Varshney A.

Presumptive Neonatal Multisystem Inflammatory Syndrome in Children Associated with Coronavirus Disease 2019

Divekar AA, Patamasucon P, Benjamin JS.

Fecal calprotectin in children with Multisystem Inflammatory Syndrome (MIS-C): a pilot case control study

Gonzalez Jimenez D, Velasco Rodríguez-Belvís M, Domínguez Ortega G, Segarra Cantón O, Diaz Martin JJ.

Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease

Scucchi L, Neri B, Sarmati L, Mossa M, Sena G, Massoud R, Petruzziello C, Musumeci M, Marafini I, Calabrese E, Lolli E, Bernardini S, Andreoni M, Monteleone G, Biancone L.

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 in a Solid Organ Transplant Recipient

Petters LM, Vogel TP, Munoz FM, Hernandez JA, Koohmaraie S, Nowicki MJ, Zumbro CE, Mysore KR.

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

Cremer PC, Abbate A, Hudock K, McWilliams C, Mehta J, Chang SY, Sheng CC, Van Tassell B, Bonaventura A, Vecchié A, Carey B, Wang Q, Wolski KE, Rajendram P, Duggal A, Wang TS, Paolini JF, Trapnell BC; MASH-COVID study group.

[COVID-19 in children: SARS-CoV-2-related inflammatory multisystem syndrome mimicking Kawasaki disease]

Mercier JC, Maroni A, Levy M, Melki I, Meinzer U, Gaschignard J, Beyler C, Santos A.

The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome

Mengozzi A, Georgiopoulos G, Falcone M, Tiseo G, Pugliese NR, Dimopoulos MA, Ghiadoni L, Barbieri G, Forfori F, Carrozzi L, Santini M, Monzani F, De Marco S, Menichetti F, Virdis A, Masi S; Pisa Covid Study Group.

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score

Dettorre GM, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, Zambelli A, Aguilar-Company J, Bower M, Sng CCT, Salazar R, Bertuzzi A, Brunet J, Mesia R, Sita-Lumsden A, Seguí E, Biello F, Generali D, Grisanti S, Seeva P, Rizzo G, Libertini M, Maconi A, Moss C, Russell B, Harbeck N, Vincenzi B, Bertulli R, Ottaviani D, Liñan R, Marrari A, Carmona-García MC, Chopra N, Tondini CA, Mirallas O, Tovazzi V, Fotia V, Cruz CA, Saoudi-Gonzalez N, Felip E, Roqué A, Lee AJX, Newsom-Davis T, GarcÃ

Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD

Selinger CP, Fraser A, Collins P, Gunn M, Chew TS, Kerry G, Patel KV, Roysam M, Bel Kok K, Bancil A, Hall V, Cooney R, Smith L, Steed H, Segal J, Kent A, Limdi J, Sebastian S.

Multisystem inflammatory syndrome in children (MIS-C) and retropharyngeal edema: A case series

Daube A, Rickert S, Madan RP, Kahn P, Rispoli J, Dapul H.

Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome

Li Z, Huang Z, Li X, Huang C, Shen J, Li S, Zhang L, Wong SH, Chan MTV, Wu WKK.

A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review

Soy M, Keser G, Atagunduz P, Mutlu MY, Gunduz A, KoybaÅŸi G, Bes C.

Cytokine Release Syndrome Biology and Management

Cobb DA, Lee DW.

Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process

Rolla R, Puricelli C, Bertoni A, Boggio E, Gigliotti CL, Chiocchetti A, Cappellano G, Dianzani U.

Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages

Recchiuti A, Patruno S, Mattoscio D, Isopi E, Pomilio A, Lamolinara A, Iezzi M, Pecce R, Romano M.

Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2

Hang W, Chen C, Zhang XA, Wang DW.

Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series

Shikhare AR, Iqbal RM, Tariq R, Turner DR, Gebara BM, Freij BJ.

Recovery does not always signal the end of the battle: A Case of Post SARS-CoV-2 Multisystem Inflammatory Syndrome in an Adult

Balan S, Beauchamps L, Gonzales-Zamora JA, Vu C, Amoros A, Quiroz T, Stevenson M, Sharkey M, Andrews DM, Abbo L.

Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients-A Report of 10 Cases

De La Flor JC, Valga F, Marschall A, Monzon T, Albarracín C, Ruiz E, Rodeles M.

First Tunisian Cluster Admissions of Critically Ill Patients with Multisystem Inflammatory Syndrome in Children (MIS-C)

Borgi A, Khadhraoui H, Louati A, Ayari A, Hajji A, Bouziri A, Menif K, Ben Jaballah N.

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?

Ghanei M.

Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes

Rahmani-Kukia N, Abbasi A.

A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms

Langarizadeh MA, Ranjbar Tavakoli M, Abiri A, Ghasempour A, Rezaei M, Ameri A.

"Silent Hypoxemia" Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It?

Chauhan A, Kaur R, Chakrbarti P, Pal A.

COVID-19-associated multisystem inflammatory syndrome in children presenting uniquely with sinus node dysfunction in the setting of shock

Tomlinson LG, Cohen MI, Levorson RE, Tzeng MB.

Fresh Per Rectal Bleeding in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)

Lad SS, Suryawanshi PB, Jadhav P, Kait SP, Lad P, Mujawar J, Khetre R, Kataria P, Balte P, Neela A, Kesarwani V, Bobba C.

Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health

Rafferty MS, Burrows H, Joseph JP, Leveille J, Nihtianova S, Amirian ES.

High rates of Antibiotic prescriptions in children with COVID-19 or Multisystem Inflammatory Syndrome: a multinational experience in 990 cases from Latin America

Yock-Corrales A, Lenzi J, Ulloa-Gutiérrez R, Gómez-Vargas J, Antúnez-Montes OY, Rios Aida JA, Del Aguila O, Arteaga-Menchaca E, Campos F, Uribe F, Parra Buitrago A, Maria Betancur Londoño L, Brizuela M, Buonsenso D.

The most important biomarker associated with coagulation and inflammation among COVID-19 patients

Hong LZ, Shou ZX, Zheng DM, Jin X.

Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent

Bastug A, Aslaner H, Aybar Bilir Y, Kemirtlek N, Gursoy FM, Bastug S, Bodur H.

Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm

Zhang J, Wu H, Yao X, Zhang D, Zhou Y, Fu B, Wang W, Li H, Wang Z, Hu Z, Ren Y, Sun R, Tian Z, Bian X, Wei H.

Scientific misinformation: A perfect storm, missteps, and moving forward

The inflammatory markers of Multisystem Inflammatory Syndrome in children (MIS-C) and adolescents associated with COVID-19: A Meta-analysis

Zhao Y, Yin L, Patel J, Tang L, Huang Y.

SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges

Shah KS, Hale Hammond ME, Drakos SG, Anderson JL, Fang JC, Knowlton KU, Shaw RM.

Correction to: Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

Ozsurekci Y, Gürlevik S, Kesici S, Akca UK, Oygar PD, Aykac K, Karacanoglu D, Nakip OS, Ilbay S, Katlan B, Ertugrul İ, Cengiz AB, Basaran O, Yayla BCC, Karakaya J, Bilginer Y, Bayrakci B, Ceyhan M, Ozen S.

What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?

Barbalho SM, Matias JN, Flato UAP, Pilon JPG, Bitelli P, Pagani Junior MA, de Carvalho ACA, Haber JFDS, Reis CHB, Goulart RA.

Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile

Vatsalya V, Li F, Frimodig J, Gala KS, Srivastava S, Kong M, Ramchandani VA, Feng W, Zhang X, McClain CJ.

Major left ventricular thrombi in an adolescent with COVID-19-associated inflammatory syndrome

Materna O, Koubský K, Pádr R, Janoušek J.

Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study

Mareev VY, Orlova YA, Plisyk AG, Pavlikova EP, Akopyan ZA, Matskeplishvili ST, Malakhov PS, Krasnova TN, Seredenina EM, Potapenko AV, Agapov MA, Asratyan DA, Dyachuk LI, Samokhodskaya LM, Mershina ЕА, Sinitsyn VE, Pakhomov PV, Zhdanova EA, Mareev YV, Begrambekova YL, Kamalov АА.

Interleukin-18 in Inflammatory Kidney Disease

Hirooka Y, Nozaki Y.

Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review)

Wang X, He Z, Zhao X.

Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children

Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, Yang KD.

SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients

Olbei M, Hautefort I, Modos D, Treveil A, Poletti M, Gul L, Shannon-Lowe CD, Korcsmaros T.

Etoricoxib may inhibit cytokine storm to treat COVID-19

Wang R.

[Correlation between early inflammation indicators and the severity of coronavirus disease 2019]

Li Y, Lin S, Zhou Y, Pan J, Chen Y.

Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2

Zhang XN, Wu LJ, Kong X, Zheng BY, Zhang Z, He ZW.

Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19

Bearse M, Hung YP, Krauson AJ, Bonanno L, Boyraz B, Harris CK, Helland TL, Hilburn CF, Hutchison B, Jobbagy S, Marshall MS, Shepherd DJ, Villalba JA, Delfino I, Mendez-Pena J, Chebib I, Newton-Cheh C, Stone JR.

Post-COVID-19 paediatric inflammatory multisystem syndrome: association of ethnicity, key worker and socioeconomic status with risk and severity

Broad J, Forman J, Brighouse J, Sobande A, McIntosh A, Watterson C, Boot E, Montgomery F, Gilmour I, Tan J, Fogarty MJ, Gomez X, Cheung R, Lillie J, Shivamurthy V, Handforth J, Miller O; PIMS-TS study group.

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey

Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, Meini A, Sottile R, Caorsi R, Zuccotti G, Fabi M, Montin D, Meneghel A, Consolaro A, Dellepiane RM, Maggio MC, La Torre F, Marchesi A, Simonini G, Villani A, Cimaz R, Ravelli A, Taddio A; Rheumatology Study Group of the Italian Pediatric Society.

Longitudinal Cytokine Profiling in Severe COVID-19 Patients on ECMO and Haemoadsorption

Lebreton G, Dorgham K, Quentric P, Combes A, Gorochov G, Schmidt M.

Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses

Lawler NG, Gray N, Kimhofer T, Boughton B, Gay M, Yang R, Morillon AC, Chin ST, Ryan M, Begum S, Bong SH, Coudert JD, Edgar D, Raby E, Pettersson S, Richards T, Holmes E, Whiley L, Nicholson JK.

SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System Syndrome

Perez-Toledo M, Faustini SE, Jossi SE, Shields AM, Marcial-Juarez E, Kanthimathinathan HK, Allen JD, Watanabe Y, Goodall M, Willcox BE, Willcox CR, Salim M, Wraith DC, Veenith TV, Syrimi E, Drayson MT, Jyothish D, Al-Abadi E, Chikermane A, Welch SB, Masilamani K, Hackett S, Crispinl M, Scholefield BR, Cunningham AF, Richter AG.

Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting

Amere Subbarao S.

A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury

Westerouen van Meeteren MJ, Van den Heuvel FM, Weijers G, Joosten LA, De Mast Q, Van de Veerdonk FL, Pickkers P, De Nooijer AH, Hoefsloot W, Drenth JP, De Korte CL, Nijveldt R, Netea MG, Tjwa ET.

ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

Lin X, Fu B, Yin S, Li Z, Liu H, Zhang H, Xing N, Wang Y, Xue W, Xiong Y, Zhang S, Zhao Q, Xu S, Zhang J, Wang P, Nian W, Wang X, Wu H.

Risk of severe coronavirus infection (COVID-19) in patients with inflammatory rheumatic diseases

Bachiller-Corral J, Boteanu A, Garcia-Villanueva MJ, de la Puente C, Revenga M, Diaz-Miguel MC, Rodriguez-Garcia A, Morell-Hita JL, Valero M, Larena C, Blazquez-Cañamero M, Guillen-Astete CA, Garrote S, Sobrino C, Medina-Quiñones C, Vazquez-Diaz M.

COVID-19 disease and the hyper-inflammatory response: Are we accusing the wrong suspect?

Afroja S, Sacchetti A.

Adaptive metabolic and inflammatory responses identified using accelerated aging metrics are linked to adverse outcomes in severe SARS-CoV-2 infection

Márquez-Salinas A, Fermín-Martínez CA, Antonio-Villa NE, Vargas-Vázquez A, C Guerra E, Campos-Muñoz A, Zavala-Romero L, Mehta R, Bahena-López JP, Ortiz-Brizuela E, González-Lara MF, Roman-Montes CM, Martinez-Guerra BA, Ponce de Leon A, Sifuentes-Osornio J, Gutiérrez-Robledo LM, Aguilar-Salinas CA, Bello-Chavolla OY.

Post COVID 19 multisystem inflammatory syndrome in an older adult

Parpas A, Yudd M, Dreisbach AW, Michaud J.

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin

Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE.

Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19

Balta MG, Papathanasiou E, Christopoulos PF.

In the Eye of the Covid-19 Storm: A Web-Based Survey of Psychological Distress Among People Living in Lombardy

Saita E, Facchin F, Pagnini F, Molgora S.

Clinical Characteristics of Paediatric Hyperinflammatory Syndrome in the Era of Corona Virus Disease 2019 (COVID-19)

Basu M, Das SK.

Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19

Vujaklija Brajković A, Zlopaša O, Gubarev Vrdoljak N, Goran T, Lovrić D, Radonic R.

Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19

Kumar D, Jahan S, Khan A, Siddiqui AJ, Redhu NS, Wahajuddin, Khan J, Banwas S, Alshehri B, Alaidarous M.

Comment on: Nature and Dimensions of the Systemic Hyper-Inflammation and its Attenuation by Convalescent Plasma in Severe COVID-19

Acosta-Ampudia Y, Rojas M, Monsalve DM, Rodríguez Y, Ramírez-Santana C, Anaya JM.

Influence of Cytokine Release Syndrome in Severe COVID-19 Patients Treated With Tocilizumab Over the Quantiferon TB Gold Plus Results

Sánchez-Martínez F, Arenas-Miras M, Jové-Caballé N, Knobel-Freud H; COVID-19 Infectious Disease Team Hospital del Mar.

In-depth Analysis of Laboratory Parameters Reveals the Interplay Between Sex, Age and Systemic Inflammation in Individuals with COVID-19

Ten-Caten F, Gonzalez-Dias P, Castro Í, Ogava RLT, Giddaluru J, Silva JCS, Martins F, Gonçalves ANA, Costa-Martins AG, Araujo JD, Viegas AC, Cunha FQ, Farsky S, Bozza FA, Levin AS, Pannaraj PS, de Silva TI, Minoprio P, Pinheiro da Silva F, Andrade BB, Nakaya HI.

Multisystem Inflammatory Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Children: A Case Series From Mayotte Island

Cattaneo C, Drean M, Subiros M, Combe P, Abasse S, Chamouine A, Simon T.

[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection]

Plusa T.

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications

Xiao N, Nie M, Pang H, Wang B, Hu J, Meng X, Li K, Ran X, Long Q, Deng H, Chen N, Li S, Tang N, Huang A, Hu Z.

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study

Abrams JY, Oster ME, Godfred-Cato SE, Bryant B, Datta SD, Campbell AP, Leung JW, Tsang CA, Pierce TJ, Kennedy JL, Hammett TA, Belay ED.

In the eye of the storm: SARS-CoV-2 infection and replication at the ocular surface?

Armstrong L, Collin J, Mostafa I, Queen R, Figueiredo FC, Lako M.

COVID-19 Related Ocular Hypertension Secondary to Anterior Uveitis as Part of a Multi-systemic Inflammatory Syndrome

Alonso RS, Alonso FOM, Fernandes BF, Ecard VO, Ventura MP.

Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic

Della Paolera S, Valencic E, Piscianz E, Moressa V, Tommasini A, Sagredini R, Kiren V, Comar M, Taddio A.

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19

Peter AE, Sandeep BV, Rao BG, Kalpana VL.

A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children - literature review based on two case reports

Poniecka A, Smolewska E.

[First Cases of Multisystem Inflammatory Syndrome following SARS-CoV-2 infection in Adults in Germany]

Rieper K, Sturm A.

Interplay between social isolation and loneliness and chronic systemic inflammation during the COVID-19 pandemic in Japan: Results from U-CORONA study

Koyama Y, Nawa N, Yamaoka Y, Nishimura H, Sonoda S, Kuramochi J, Miyazaki Y, Fujiwara T.

(18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine

Steinberg J, Thomas A, Iravani A.

HLA class I-associated expansion of TRBV11-2 T cells in Multisystem Inflammatory Syndrome in Children

Porritt RA, Paschold L, Noval Rivas M, Cheng MH, Yonker LM, Chandnani H, Lopez M, Simnica D, Schultheiß C, Santiskulvong C, van Eyk J, McCormick JK, Fasano A, Bahar I, Binder M, Arditi M.

Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden

Ludvigsson JF, Axelrad J, Halfvarson J, Khalili H, Larsson E, Lochhead P, Roelstraete B, Simon TG, Söderling J, Olén O.

Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers

Bhat S, Caldera F, Farraye FA.

The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication - a cross sectional study over 3 months in Germany

Hasseli R, Müller-Ladner U, Keil F, Broll M, Dormann A, Fräbel C, Hermann W, Heinmüller CJ, Hoyer BF, Löffler F, Özden F, Pfeiffer U, Saech J, Schneidereit T, Schlesinger A, Schwarting A, Specker C, Stapfer G, Steinmüller M, Storck-Müller K, Strunk J, Thiele A, Triantafyllias K, Vagedes D, Wassenberg S, Wilden E, Zeglam S, Schmeiser T.

The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System

Lipcsey M, Persson B, Eriksson O, Blom AM, Fromell K, Hultström M, Huber-Lang M, Ekdahl KN, Frithiof R, Nilsson B.

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Thwaites RS, Sanchez Sevilla Uruchurtu A, Siggins MK, Liew F, Russell CD, Moore SC, Fairfield C, Carter E, Abrams S, Short CE, Thaventhiran T, Bergstrom E, Gardener Z, Ascough S, Chiu C, Docherty AB, Hunt D, Crow YJ, Solomon T, Taylor GP, Turtle L, Harrison EM, Dunning J, Semple MG, Baillie JK, Openshaw PJ; ISARIC4C investigators.

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

Creeden JF, Imami AS, Eby HM, Gillman C, Becker KN, Reigle J, Andari E, Pan ZK, O'Donovan SM, McCullumsmith RE, McCullumsmith CB.

Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19

Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ.

Identification of human immune cell subtypes most responsive to IL-1β-induced inflammatory signaling using mass cytometry

Kothari H, Williams CM, McSkimming C, Drago F, Marshall MA, Garmey J, Vigneshwar M, Zunder ER, McNamara CA.

Managing COVID-19 in patients with inflammatory bowel disease: navigating unprecedented challenges

Prentice RE, Al-Ani A, Christensen B.

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra

Mortaz E, Bassir A, Dalil Roofchayee N, Dezfuli NK, Jamaati H, Tabarsi P, Moniri A, Rezaei M, Mehrian P, Varahram M, Marjani M, Mumby S, Adcock IM.

Latin America and chronic diseases: A perfect storm during the COVID-19 pandemic

Pizuorno A, Fierro NA.

Response to Zhou et al. regarding Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19)

Tan A, Jones DM, Ahmad M.

Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup

Rubin EJ, Longo DL, Baden LR.

Postoperative inflammation to "hyper"-inflammation: cryptic COVID-19 connections!

Magoon R, ItiShri, Kaur Kohli J, Kashav R.

Otolaryngologic Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19

Cheong RCT, Jephson C, Frauenfelder C, Cavalli L, Moshal K, Butler CR, Wyatt ME.

CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients

Hernandez-Cedeño M, Venegas-Rodriguez R, Peña-Ruiz R, Bequet-Romero M, Santana-Sanchez R, Penton-Arias E, Martinez-Donato G, Guillén-Nieto G, Dominguez-Horta MDC.

Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response

Pearce L, Davidson SM, Yellon DM.

Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome

Du P, Geng J, Wang F, Chen X, Huang Z, Wang Y.

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Furer V, Rondaan C, Agmon-Levin N, van Assen S, Bijl M, Kapetanovic MC, de Thurah A, Mueller-Ladner U, Paran D, Schreiber K, Warnatz K, Wulffraat NM, Elkayam O.

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines

Schulze-Koops H, Specker C, Skapenko A.

Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19

Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, Jeanpierre E, Goutay J, Caplan M, Varlet P, Lefevre G, Lassalle F, Bauters A, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Vincent F, Rousse N, Kipnis E, Lenting P, Poissy J, Susen S; Lille Covid Research Network (LICORNE).

Inflammatory arthritis in patients with COVID-19

Conway R, Konig MF, Graef ER, Webb K, Yazdany J, Kim AHJ.

Letter by Brambilla et al Regarding Article, "Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia"

Brambilla M, Canzano P, Tremoli E, Camera M.

Multisystem Inflammatory Syndrome in Children Temporarily Associated with SARS-CoV-2

Ratageri VH, Pawar GR, N G, Maldar SB, Illau S.

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19

Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, Soma VL, Maddux AB, Mourani PM, Bowens C, Maamari M, Hall MW, Riggs BJ, Giuliano JS Jr, Singh AR, Li S, Kong M, Schuster JE, McLaughlin GE, Schwartz SP, Walker TC, Loftis LL, Hobbs CV, Halasa NB, Doymaz S, Babbitt CJ, Hume JR, Gertz SJ, Irby K, Clouser KN, Cvijanovich NZ, Bradford TT, Smith LS, Heidemann SM, Zackai SP, Wellnitz K, Nofziger RA, Horwitz SM, Carroll RW, Rowan CM, Tarquinio KM, Mack EH, Fitzgerald JC, Coates BM, Ja

COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of (18)F-FDG PET/CT to assess myocardial involvement

Satapathy S, Kumar R, Kavanal AJ, Krishnaraju VS, Ramachandran A, Deo P, Dhir V, Mittal BR.

Immunity, parasites, genetics and sex hormones: contributors to mild inflammatory responses in COVID-19?

Munjita SM, Samutela M, Ndashe K, Munsaka SM.

Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19

Vassiliou AG, Dimopoulou I, Jahaj E, Keskinidou C, Mastora Z, Orfanos SE, Kotanidou A.

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Bower H, Frisell T, Di Giuseppe D, Delcoigne B, Ahlenius GM, Baecklund E, Chatzidionysiou K, Feltelius N, Forsblad-d'Elia H, Kastbom A, Klareskog L, Lindqvist E, Lindström U, Turesson C, Sjöwall C, Askling J; ARTIS Study Group.

Acute and chronic inflammatory neuropathies and COVID-19 vaccines: practical recommendations from the task force of the Italian Peripheral Nervous System Association (ASNP)

Doneddu PE, Spina E, Briani C, Fabrizi GM, Manganelli F, Nobile-Orazio E; Italian Peripheral Nervous System Association (ASNP).

Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7

Xie C, Chen Y, Luo D, Zhuang Z, Jin H, Zhou H, Li X, Lin H, Zheng X, Zhang J, Wang P, Zhao J, Zhao Y, Huang H.

Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19

Kheirkhah AH, Shahcheraghi SH, Lotfi M, Lotfi M, Raeisi S, Mirani Z.

Maxillofacial surgery beyond the perfect storm of COVID-19

Kwon TG.

Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality

Que Y, Hu C, Wan K, Hu P, Wang R, Luo J, Li T, Ping R, Hu Q, Sun Y, Wu X, Tu L, Du Y, Chang C, Xu G.

Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases

Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, De Jager PL; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative.

The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C)

Mahmoud S, Fouda EM, Kotby A, Ibrahim HM, Gamal M, El Gendy YG, Zaky EA, Amr NH, El-Ghoneimy DH, Alsharkawy AA, Omar A, El-Meteini M, Elhodhod M.

Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System

Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL.

Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2

Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB, Bashoura L, Tayar J, Dailey Garnes N, Petropoulos D, Tewari P, Bhatti M, Ahmad AH, Cortes J, Razvi S, McBeth K, Swinford R, Shoberu B, Waseemuddin W, Chi L, Gill JB, Zaky W, Daw N, Gutierrez C, Tereffe W, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Mahadeo KM.

High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses

Xie M, Yunis J, Yao Y, Shi J, Yang Y, Zhou P, Liang K, Wan Y, Mehdi A, Chen Z, Wang N, Xu S, Zhou M, Yu M, Wang K, Tao Y, Zhou Y, Li X, Liu X, Yu X, Wei Y, Liu Z, Sprent J, Yu D.

Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents

Fernandez-Gutierrez B, Leon L, Madrid A, Rodriguez-Rodriguez L, Freites D, Font J, Mucientes A, Culebras E, Colome JI, Jover JA, Abasolo L.

Preferences of Inflammatory Arthritis Patients for Biological Disease-Modifying Antirheumatic Drugs in the First 100 Days of COVID-19 Pandemic

Kalyoncu U, Pehlİvan Y, Akar S, KaŞİfoĞlu T, Kİmyon G, KaradaĞ Ö, DalkiliÇ HE, Ertenlİ Aİ, KiliÇ L, ErsÖzlÜ ED, Bes C, Emmungİl H, Mercan R, EdİboĞlu E, Alpay Kanitez N, Bİlgİn E, Çolak S, Koca SS, GÖnÜllÜ E, KÜÇÜkŞahİn O, CoŞkun BN, YaĞiz B, Kİraz S.

Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?

Collier ME, Zhang S, Scrutton NS, Giorgini F.

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K.

Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction

Reffo E, Stritoni V, Di Salvo G.

Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center

Kumar Gothwal S, Singh VB, Shrivastava M, Banseria R, Goyal K, Singh S, Ali H, Saad Alharbi K, Singh Y, Gupta G.

Multisystem inflammatory syndrome in pediatric COVID-19 patients: a meta-analysis

Toraih EA, Hussein MH, Elshazli RM, Kline A, Munshi R, Sultana N, Taghavi S, Killackey M, Duchesne J, Fawzy MS, Kandil E.

Very fast-progressive pulmonary opacities and high inflammatory factors levels are associated with decease of young Coronavirus Disease 2019 patients

Zhang Q, Xiong Y, Wu T, Zhu W.

COVID-19, cytokines, inflammation, and spices: How are they related?

Kunnumakkara AB, Rana V, Parama D, Banik K, Girisa S, Sahu H, Thakur KK, Dutta U, Garodia P, Gupta SC, Aggarwal BB.

COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy

Van Looy E, Veenker L, Steyaert A, Leenders J, Malfroid G, De Cauwer H.

HIV-1 Infection Does Not Change Disease Course or Inflammatory Pattern of SARS-CoV-2-Infected Patients Presenting at a Large Urban Medical Center in New York City

Laracy J, Zucker J, Castor D, McMahon DJ, Guo TW, Yan M, Shalev N, Scherer M, Gordon P, Sobieszczyk M, Yin MT.

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study

Cardillo G, Viggiano GV, Russo V, Mangiacapra S, Cavalli A, Castaldo G, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Fontanella A, Di Micco P; FondenoxavidStudy Group.

Weathering the Storm: Psychological Impact of COVID-19 Pandemic on Clinical and Nonclinical Healthcare Workers in India

Sunil R, Bhatt MT, Bhumika TV, Thomas N, Puranik A, Chaudhuri S, Shwethapriya R.

Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters

Gao Y, Chen L, Chi J, Zeng S, Feng X, Li H, Liu D, Feng X, Wang S, Wang Y, Yu R, Yuan Y, Xu S, Li C, Zhang W, Li S, Gao Q.

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

Hoste L, Van Paemel R, Haerynck F.

[Pediatric COVID-19 - Pathophysiology, immune responses, genetic predispositions, hyperinflammatory syndrome]

Blanchard-Rohner G, Pachlopnik Schmid J, Candotti F, Hofer M.

Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply

Al-Ani AH, Prentice RE, Rentsch C, Christensen B.

Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal

Shabrish S, Mittra I.

SARS-CoV-2 viremia is associated with inflammatory, but not cardiovascular biomarkers, in patients hospitalized for COVID-19

Myhre PL, Prebensen C, Monceyron Jonassen C, Erik Berdal J, Omland T.

In the eye of a quiet storm: A critical incident study on the quarantine experience during the coronavirus pandemic

Durosini I, Triberti S, Savioni L, Pravettoni G.

Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study

Naravane AV, Mundae R, Zhou Y, Santilli C, van Kuijk FJGM, Nazari H, Yamanuha J, Emerson GG, Koozekanani DD, Montezuma SR.

Imaging in support of the clinical diagnoses of COVID-19 and multisystem inflammatory syndrome in children

Trout AT, Westra SJ.

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown

Sindal MD, Chhabra K, Khanna V.

A case report on transient cardiomyopathy with cytokine storm in SARS-CoV-2

Tarun T, Kumar S, Johnson J, Chockalingam A.

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'

De Santis M, Voza A, Savevski V, Badalamenti S, Cecconi M, Mantovani A, Selmi C.

Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by De Santis et al

Ramiro S, Mostard RLM, Landewé RBM.

Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19

Fadai NT, Sachak-Patwa R, Byrne HM, Maini PK, Bafadhel M, Nicolau DV Jr.

Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study

Attauabi M, Seidelin JB, Felding OK, Wewer MD, Vinther Arp LK, Sarikaya MZ, Egeberg A, Vladimirova N, Bendtsen F, Burisch J.

Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study

Zhang W, Sang L, Shi J, Zhong M, Jiang L, Song B, Kang L, Zhang Y, Zhang D, Yu Y, Zheng X.

Respiratory mechanics heterogeneity is related to inflammatory biomarkers in acute respiratory distress syndrome due to COVID-19

Menga LS, Ferrante MC, Paiano G, Sessa F, Grieco DL, Antonelli M; Gemelli COVID2-ICU study group.

Severe Foodborne Bacterial Infections Mimicking Multisystem Inflammatory Syndrome in Children Associated With COVID-19

Toledano J, Saavedra-Lozano J, Navarro-Gómez ML, Santiago-García B, Aguilera-Alonso D.

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'

Charles P.

Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles

Ramiro S, Mostard RLM, Landewé RBM.

Increased Intracranial Hemorrhage Amid Elevated Inflammatory Markers in those with COVID-19 Supported with Extracorporeal Membrane Oxygenation

Bermea RS, Raz Y, Sertic F, Rubin J, Wolf M, Olia S, Richards T, Crowley J, Funamoto M, Shelton K, Bermudez C.

Prophylactic anticoagulation: comment on the American College of Rheumatology Guidance for Management of Multisystem Inflammatory Syndrome in Children

Faganel Kotnik B, Zajc Avramovič M, Kitanovski L, Avčin T.

Reply to Prophylactic Anticoagulation: Comment on the ACR Guidance for Management of Multisystem Inflammatory Syndrome in Children

Henderson LA, Friedman KG, Kernan KF, Canna SW, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Ferris A, Schulert GS, Seo P, Son MBF, Tremoulet AH, Yeung RSM, Karp DR, Mehta JJ.

Mesenchymal stromal cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

Song N, Wakimoto H, Rossignoli F, Bhere D, Ciccocioppo R, Chen KS, Khalsa JK, Mastrolia I, Samarelli AV, Dominici M, Shah K.

Thrombo-inflammatory Biomarkers in COVID-19: Systematic Review and Meta-analysis of 17,052 patients

Chaudhary R, Garg J, Houghton DE, Murad MH, Kondur A, Chaudhary R, Wysokinski WE, McBane RD 2nd.

Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019

Nagoor Meeran MF, Javed H, Sharma C, Goyal SN, Kumar S, Jha NK, Ojha S.

Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure

Taliani G, Follini E, Guglielmetti L, Bernuzzi P, Faggi A, Ferrante P, Fronti E, Gerna L, Leoni MC, Paolillo F, Ratti G, Ruggieri A, Valdatta C, Donisi A, Zangrandi A, Pochintesta L, Moroni C, Sacchini D, Vallisa D, Codeluppi M; COVID-Piacenza Group.

"Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: A single center experience", a retrospective study-original article

Chachar AZK, Khan KA, Iqbal J, Shahid AH, Asif M, Fatima SA, Khan AA, Younis BB.

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

Gu T, Zhao S, Jin G, Song M, Zhi Y, Zhao R, Ma F, Zheng Y, Wang K, Liu H, Xin M, Han W, Li X, Dong CD, Liu K, Dong Z.

The Impact of Polyphenols-Based Diet on the Inflammatory Profile in COVID-19 Elderly and Obese Patients

Santos JC, Ribeiro ML, Gambero A.

Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19

Vorobjeva NV, Sud'ina GF, Chernyak BV.

Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury

Jin H, Zhao Z, Lan Q, Zhou H, Mai Z, Wang Y, Ding X, Zhang W, Pi J, Evans CE, Liu X.

Cardiac Manifestations, Treatment Characteristics, and Outcomes of Paediatric Inflammatory Multisystem Syndrome Temporally Associated with Severe Acute Respiratory Syndrome Coronavirus-2: systematic review of case reports and case series

Henrina J, Putra ICS, Lawrensia S, Marta DS, Wijaya E, Saboe A, Cool CJ, Suciadi LP.

Multisystem Inflammatory Syndrome (MIS-C) in an Adolescent Nigerian Girl with COVID-19: A call for vigilance in Africa

Onyeghala C, Alasia D, Eyaru O, Nsirim P, Maduka O, Osemwengie N, Ugwueze N, Ordu C, Igbosi E, Irabor M, Eyidia E.

Hyper-Inflammatory Response Involves in Cardiac Injury among Patients with Coronavirus Disease 2019

Xia G, Fan D, Ma C, He Y, Wang M, Zhu Y, Zheng Q.

GBM nephritis - Crescentic renal inflammation and immunosuppressive intervention in the time of the SARS-CoV-2 pandemic

Brix SR, Jones RB, Jayne DRW.

Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm

Clark IA.

Remestemcel-L Therapy for COVID-19-Associated Multisystem Inflammatory Syndrome in Children

Ross Eckard A, Borow KM, Mack EH, Burke E, Atz AM.

Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey

Cheema M, Mitrev N, Hall L, Tiongson M, Ahlenstiel G, Kariyawasam V.

The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression

Huang W, Li M, Luo G, Wu X, Su B, Zhao L, Zhang S, Chen X, Jia M, Zhu J, Su W, Zhang D.

Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications

Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C.

Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean

Ozsurekci Y, Gürlevik S, Kesici S, Akca UK, Oygar PD, Aykac K, Karacanoglu D, Sarıtas Nakip O, Ilbay S, Katlan B, Cengiz AB, Basaran O, Cura Yayla BC, Karakaya J, Bilginer Y, Bayrakci B, Ceyhan M, Ozen S.

The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients

Tjan LH, Nagano T, Furukawa K, Nishimura M, Arii J, Fujinaka S, Iwata S, Sano S, Tohma Y, Nishimura Y, Mori Y.

"In the Same Storm, but Not on the Same Boat": Children Grief During the COVID-19 Pandemic

Albuquerque S, Santos AR.

The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved

Coperchini F, Chiovato L, Ricci G, Croce L, Magri F, Rotondi M.

Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells

Takahashi Y, Watanabe N, Kamio N, Yokoe S, Suzuki R, Sato S, Iinuma T, Imai K.

Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota

Rueda Ruzafa L, Cedillo JL, Hone AJ.

Time to Negative SARS-CoV-2 PCR Should Not Delay Care Among Patients With Inflammatory Bowel Diseases

Winter RW, Ananthakrishnan A, Burke KE, Kochar B, Chan WW, Allegretti JR.

Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases

Municio C, Criado G.

Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?

Vignesh R, Swathirajan CR, Tun ZH, Rameshkumar MR, Solomon SS, Balakrishnan P.

Overview on the Discovery and Development of Anti-Inflammatory Drugs: Should the Focus Be on Synthesis or Degradation of PGE(2)?

Mahesh G, Anil Kumar K, Reddanna P.

Photosynthetically Controlled Spirulina, but Not Solar Spirulina, Inhibits TNF-α Secretion: Potential Implications for COVID-19-Related Cytokine Storm Therapy

Tzachor A, Rozen O, Khatib S, Jensen S, Avni D.

miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations

Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G.

A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol

Anushiravani A, Vahedi H, Fakheri H, Mansour-Ghanaei F, Maleki I, Nasseri-Moghaddam S, Vosoghinia H, Ghadir MR, Hormati A, Aminisani N, Radmard AR, Khosravi B, Saberzadeh-Ardestani B, Malekzadeh M, Alatab S, Sadeghi A, Salahi S, Malekzadeh R, Sima AR.

Off-label therapy targeting pathogenic inflammation in COVID-19

Romani L, Tomino C, Puccetti P, Garaci E.

COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment

Welzel T, Samba SD, Klein R, van den Anker JN, Kuemmerle-Deschner JB.

REPLY to letters to the editor regarding manuscript Rubin DT, Feuerstein JD, Wang AY, Cohen RD, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020)

Cohen RD, Feuerstein JD, Rubin DT.

Orbital Inflammation with Optic Perineuritis in Association with COVID-19

Dinkin M, Feinberg E, Oliveira C, Tsai J.

The impact of national lockdown on nutritional status of children with inflammatory bowel disease

Marino LV, Ashton JJ, Beattie RM.

Cardiorespiratory Fitness, Inflammation, and the Incident Risk of Pneumonia

Jae SY, Heffernan KS, Kurl S, Kunutsor SK, Kim CH, Johnson BD, Franklin BA, Laukkanen JA.

The cytokine storm and thyroid hormone changes in COVID-19

Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, Chiovato L.

"COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment"

Munavalli GG, Guthridge R, Knutsen-Larson S, Brodsky A, Matthew E, Landau M.

Signs of self-sustained inflammatory circuits in severe COVID pneumonia

Mould KJ, Janssen WJ.

Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes

England JT, Abdulla A, Biggs CM, Lee AYY, Hay KA, Hoiland RL, Wellington CL, Sekhon M, Jamal S, Shojania K, Chen LYC.

Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics

Cattalini M, Taddio A, Bracaglia C, Cimaz R, Paolera SD, Filocamo G, La Torre F, Lattanzi B, Marchesi A, Simonini G, Zuccotti G, Zunica F, Villani A, Ravelli A; Rheumatology Study Group of the Italian Society of Pediatrics.

Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia

Pontali E, Volpi S, Signori A, Antonucci G, Castellaneta M, Buzzi D, Montale A, Bustaffa M, Angelelli A, Caorsi R, Giambruno E, Bobbio N, Feasi M, Gueli I, Tricerri F, Calautti F, Castagnola E, Moscatelli A, Rollandi GA, Ravelli A, Cassola G, Sormani MP, Gattorno M.

Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome

Smith SW, Strobel AM, Saenger AK, Apple FS.

The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)

Henry BM, Benoit SW, Vikse J, Berger BA, Pulvino C, Hoehn J, Rose J, Santos de Oliveira MH, Lippi G, Benoit JL.

Cytokine "storm", cytokine "breeze", or both in COVID-19?

Lippi G, Plebani M.

Hemocytometric characteristics of COVID-19 patients with and without cytokine Storm syndrome on the Sysmex XN-10 hematology analyzer

Martens RJH, van Adrichem AJ, Mattheij NJA, Brouwer CG, van Twist DJL, Broerse JJCR, Magro-Checa C, van Dongen CMP, Mostard RLM, Ramiro S, Landewé RBM, Leers MPG.

Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19

Patel S, Saxena B, Mehta P.

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma

Bonny TS, Patel EU, Zhu X, Bloch EM, Grabowski MK, Abraham AG, Littlefield K, Shrestha R, Benner SE, Laeyendecker O, Shoham S, Sullivan D, Quinn TC, Casadevall A, Pekosz A, Redd AD, Tobian AAR.

Clinical manifestations of blood cell parameters and inflammatory factors in 92 patients with COVID-19

Deng R, Wang C, Ye Y, Gou L, Fu Z, Ye B, Shao F, Zhang X, Fu W, Xiao J, Li T, Qi H, Li C.

Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco

Wafa A, Hicham H, Hajar K, Mouna M, Zoubida MT, Mohamed A.

The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial

Luo Z, Chen W, Xiang M, Wang H, Xiao W, Xu C, Li Y, Min J, Tu Q.

Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus

Dobson GP, Biros E, Letson HL, Morris JL.

Delving Into the Origin of Destructive Inflammation in COVID-19: A Betrayal of Natural Host Defense Peptides?

Garcia-Fandino R, Piñeiro Á.

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences

Meng J, Ma Y, Jia J, Wang M, Teng J, Shi H, Liu H, Su Y, Ye J, Sun Y, Cheng X, Chi H, Liu T, Zhu D, Zhou Z, Wan L, Wang Z, Wang F, Qiao X, Chen X, Zhang H, Tang Z, Yang C, Hu Q.

Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Marafini I, Troncone E, Rocchetti I, Monteleone G.

Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients

DiNicolantonio JJ, O'Keefe JH.

COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

Macciò A, Oppi S, Madeddu C.

[Hypoxia and inflammation are risk factors for acute myocardial injury in patients with coronavirus disease 2019]

Yang LC, Zhang RT, Guo LJ, Xiao H, Zu LY, Zhang YY, Cheng Q, Zhao ZL, Ge QG, Gao W.

Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19

Sayah W, Berkane I, Guermache I, Sabri M, Lakhal FZ, Yasmine Rahali S, Djidjeli A, Lamara Mahammed L, Merah F, Belaid B, Berkani L, Lazli NZ, Kheddouci L, Kadi A, Ouali M, Khellafi R, Mekideche D, Kheliouen A, Hamidi RM, Ayoub S, Raaf NB, Derrar F, Gharnaout M, Allam I, Djidjik R.

Colchicine and SARS-CoV-2: Management of the hyperinflammatory state

Vitiello A, Ferrara F.

COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases

Dalal RS, McClure E, Marcus J, Winter RW, Hamilton MJ, Allegretti JR.

SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical?

Nowak JK, Kalla R, Satsangi J.

COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?

Zhao Y, Chen M, Yang X, Zhao L.

Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force

Ayesha B, Kumthekar A, Jain R, Patel S, Ramesh M, Ferastraoaru DE, Hudes G, Karagic M, Zafar S, Bartash R, Vasquez-Canizares N, Kitsis E, Tagoe C, Wahezi DM, Rubinstein T, Broder A.

Inflammatory cytokine patterns associated with neurological diseases in COVID-19

Espíndola OM, Gomes YCP, Brandão CO, Torres RC, Siqueira M, Soares CN, Lima MASD, Leite ACCB, Venturotti CO, Carvalho AJC, Torezani G, Araujo AQC, Silva MTT.

[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers]

Stallmach A, Sturm A, Blumenstein I, Helwig U, Koletzko S, Lynen P, Schmidt C, Dignaß A, Kucharzik T; Collaborators:.

Inflammatory bowel disease is associated with higher seroprevalence rates of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Łodyga M, Maciejewska K, Eder P, Waszak K, Stawczyk-Eder K, Michalak M, Dobrowolska A, Wiśniewska-Jarosińska M, Gąsiorowska A, Cicha M, Wierzba W, Rydzewska G.

COVID-19 versus Non-COVID ARDS: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers and Clinical Outcomes

Bain W, Yang H, Shah FA, Suber T, Drohan C, Al-Yousif N, DeSensi RS, Bensen N, Schaefer C, Rosborough BR, Somasundaram A, Workman CJ, Lampenfeld C, Cillo AR, Cardello C, Shan F, Bruno TC, Vignali DA, Ray P, Ray A, Zhang Y, Lee JS, Methé B, McVerry BJ, Morris A, Kitsios GD.

Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report

Colombier S, Mahendiran T, Niclauss L, Kirsch M.

Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients

Jiang N, Li Z, Yang B, Jin M, Sun Y, He Y, Liu Y, Wang Y, Si D, Ma P, Zhang J, Liu T, Yu Q.

Intracranial inflammatory mediators involved in SARS-CoV-2 neurological manifestations?

Flemming A.

miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells

Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G.

Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea

Choe YJ, Choi EH, Choi JW, Eun BW, Eun LY, Kim YJ, Kim YH, Kim YA, Kim YK, Kwak JH, Lee HM, Lee H, Lee JK, Park JD, Kim EJ, Park YJ, Gwack J, Lee SW.

Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?

Schlabitz F, Teich N, Riesner-Wehner A, Böhm S, Greinert R, Eisenmann S, Michl P, Walldorf J.

Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection

Maggi P, Ricci E, Messina V, Salzillo A, Simeone F, Iodice A, Socio GV.

Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19

Caterino M, Gelzo M, Sol S, Fedele R, Annunziata A, Calabrese C, Fiorentino G, D'Abbraccio M, Dell'Isola C, Fusco FM, Parrella R, Fabbrocini G, Gentile I, Andolfo I, Capasso M, Costanzo M, Daniele A, Marchese E, Polito R, Russo R, Missero C, Ruoppolo M, Castaldo G.

Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19

Jung S, Potapov I, Chillara S, Del Sol A.

Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge: A Prospective Cohort and Nested Case-Control Study

Li L, Gou CY, Li XM, Song WY, Wang XJ, Li HY, Li HY, Li XH.

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond

Beecker J, Papp KA, Dutz J, Vender RB, Gniadecki R, Cooper C, Gisondi P, Gooderham M, Hong CH, Kirchhof MG, Lynde CW, Maari C, Poulin Y, Puig L.

SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface

Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM, Tang Z, Pope SD, Song E, Vogels CBF, Lu-Culligan WJ, Campbell KH, Casanovas-Massana A, Bermejo S, Toothaker JM, Lee HJ, Liu F, Schulz W, Fournier J, Muenker MC, Moore AJ, Konnikova L, Neugebauer KM, Ring A, Grubaugh ND, Ko AI, Morotti R, Guller S, Kliman HJ, Iwasaki A, Farhadian SF.

COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region

Ghatasheh G, Al Dhanhani H, Goyal A, Noureddin MB, Al Awaad D, Peerwani Z.

Local Nasal Response Against COVID-19: Debate Regarding the Absence of Nasal Inflammatory Symptoms

Sayin I, Yazici ZM, Akgül A.

Neuroinflammation and Brain Development: Possible Risk Factors in COVID-19-Infected Children

da Silva Chagas L, Sandre PC, de Velasco PC, Marcondes H, Ribeiro E Ribeiro NCA, Barreto AL, Alves Mauro LB, Ferreira JH, Serfaty CA.

Genetic Variation, Diet, Inflammation, and the Risk for COVID-19

Simopoulos AP.

Itolizumab Treatment for Cytokine Release Syndrome in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: Clinical Outcomes, A Retrospective Study

Gore V, Kshirsagar DP, Bhat SM, Khatib KI, Mansukhani B.

Autoimmune and Chronic Inflammatory Disease Patients with COVID-19

Ungaro RC, Agrawal M, Park S, Hirten R, Colombel JF, Twyman K, Gulko PS, Klang E.

Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein

Koh H, Moh AMC, Yeoh E, Lin Y, Low SKM, Ooi ST, Tan SK, Lin JHX, Hoong CWS.

Management of inflammatory bowel disease in the COVID-19 era

Kim KO, Jang BI.

COVID-19 and NF-kB: The Hepcidin paradox and the Iron Storm - Reply

Banchini F.

Reply to Letter to the Editor - in response to: Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19)

Zhou W, Wang Y, Zheng Y.

Increased PD-L1 expression may be associated with the cytokine storm and CD8 + T-cell exhaustion in severe COVID-19

Chen J, Vitetta L.

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children

Ouldali N, Toubiana J, Antona D, Javouhey E, Madhi F, Lorrot M, Léger PL, Galeotti C, Claude C, Wiedemann A, Lachaume N, Ovaert C, Dumortier M, Kahn JE, Mandelcwajg A, Percheron L, Biot B, Bordet J, Girardin ML, Yang DD, Grimaud M, Oualha M, Allali S, Bajolle F, Beyler C, Meinzer U, Levy M, Paulet AM, Levy C, Cohen R, Belot A, Angoulvant F; French Covid-19 Paediatric Inflammation Consortium.

COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue

Xi Y.

Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease

Scharrer S, Kutschera M, Weseslindtner L, Primas C, Vogelsang H.

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?

Favalli EG, Caporali R.

Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis

Mehta P, Haskard DO, Laffan MA, Chambers RC, Hunt BJ.

Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab

Agresti N, Lalezari JP, Amodeo PP, Mody K, Mosher SF, Seethamraju H, Kelly SA, Pourhassan NZ, Sudduth CD, Bovinet C, ElSharkawi AE, Patterson BK, Stephen R, Sacha JB, Wu HL, Gross SA, Dhody K.

CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same

García-Salido A, Cuenca-Carcelén S, Castillo-Robleda A.

Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies

Li S, Wang W, Li T, Han X, Hu C, Wang Y, Shen M, Du L, Nai Y, Wang J, Jin A.

Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19

Morenikeji OB, Bernard K, Strutton E, Wallace M, Thomas BN.

Corrigendum to "A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm)" [ID Cases 21 (2020) e00829]

Chettri S, Khamis F, Pandak N, Al Khalili H, Said E, Petersen E.

Detecting the Multiomics Signatures of Factor-Specific Inflammatory Effects on Airway Smooth Muscles

Zhang YH, Li Z, Zeng T, Chen L, Li H, Huang T, Cai YD.

Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury

Li X, Berg NK, Mills T, Zhang K, Eltzschig HK, Yuan X.

COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments

Soldevila-Domenech N, Tío L, Llorente-Onaindia J, Martín-García E, Nebot P, de la Torre R, Gurt A, Maldonado R, Monfort J; Covidmar Study Group.

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19

Hyder Pottoo F, Abu-Izneid T, Mohammad Ibrahim A, Noushad Javed M, AlHajri N, Hamrouni AM.

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms

Khan MA, Khan ZA, Charles M, Pratap P, Naeem A, Siddiqui Z, Naqvi N, Srivastava S.

Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient

Chavarot N, Burger C, Aguilar C, Scemla A, Sberro-Soussan R, Amrouche L, Leruez-Ville M, Martinez F, Legendre C, Anglicheau D, Zuber J.

Compelling evidence of a novel multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection

Long SS.

Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients

T U, Am DR, Bm W, Ar H, F P, A L, Sg D, L H, Jc H, P A.

Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease

Navarro-Correal E, Borruel N, Robles V, de Guise CH, Ayala LFM, Martínez ZP, Casas AI, Rodríguez SA, Duelt IJB, Alcaide JG, Branchadell SL, Zuriguel-Perez E, Casellas F.

Identifying prognostic risk factors for poor outcome following COVID-19 disease among in-centre haemodialysis patients: role of inflammation and frailty

Hendra H, Vajgel G, Antonelou M, Neradova A, Manson B, Clark SG, Kostakis ID, Caplin B, Salama AD.

Influence of respiratory and inflammatory parameters preceding intubation on survival of patients with COVID-19 ARDS- A single centre retrospective analysis

Arulkumaran N, Green J, Khan A, Bonnici T, Longobardo A, Singer M.

Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India

Gupta Dch S, Chopra Md N, Singh Md A, Gera R, Chellani Md H, Pandey PhD R, Arora Md BS.

Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic")

Eltabbakh M, Alaty WA, Sakr MA, Sherief AF.

Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic"

Khorshid M, AbdAllah M.

Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19

Li XZ, Qiu Y, Jeffery L, Liu F, Feng R, He JS, Tan JY, Ye ZY, Lin SN, Ghosh S, Iacucci M, Chen MH, Mao R.

Kawasaki Disease like Multisystem Inflammatory Syndrome in a Toddler during SARS-CoV-2 Pandemic in Nepal

Rayamajhi A, Sharma M, Deo MK, Shrestha S, Bista KP, Paudel KP.

Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al

Shah B, Reyes AZ, Hu KA, Teperman J, Wampler Muskardin TL, Tardif JC, Pillinger MH.

Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'

Al Nokhatha S, MacEoin N, Conway R.

Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha et al

Dejaco C, Bijlsma JW, Buttgereit F.

Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'

Perricone C, Bartoloni E, Cafaro G, Caporali R, Gerli R.

Anti-inflammatory potential of Quercetin in COVID-19 treatment

Saeedi-Boroujeni A, Mahmoudian-Sani MR.

SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement

Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N; Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group.

Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients

Remsik J, Wilcox JA, Babady NE, McMillen TA, Vachha BA, Halpern NA, Dhawan V, Rosenblum M, Iacobuzio-Donahue CA, Avila EK, Santomasso B, Boire A.

High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response

López Zúñiga MÁ, Moreno-Moral A, Ocaña-Granados A, Padilla-Moreno FA, Castillo-Fernández AM, Guillamón-Fernández D, Ramírez-Sánchez C, Sanchez-Palop M, Martínez-Colmenero J, Pimentel-Villar MA, Blázquez-Roselló S, Moreno-Sánchez JJ, López-Vílchez M, Prior-Sánchez I, Jódar-Moreno R, López Ruz MÁ.

Different Hair Loss Patterns in Two Pediatric Patients with COVID-19 Associated Multisystem Inflammatory Syndrome in Children (MIS-C)

Hayran Y, Yorulmaz A, Gür G, Aktaş A.

Clinical Significance of Cellular Immunity Function and Inflammatory Factors Assays in Alveolar Lavage Fluid for Severe COVID-19 Pneumonia

Liao L, Yang GH.

RAAS blockade and COVID-19: Mechanistic Modeling of mas and AT1 Receptor Occupancy as Indicators of Pro- and Anti-Inflammatory Balance

Hallow KM, Dave I.

Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients

Matteucci C, Minutolo A, Balestrieri E, Petrone V, Fanelli M, Malagnino V, Ianetta M, Giovinazzo A, Barreca F, Di Cesare S, De Marco P, Miele MT, Toschi N, Mastino A, Sinibaldi Vallebona P, Bernardini S, Rogliani P, Sarmati L, Andreoni M, Grelli S, Garaci E.

The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families

Reinsch S, Stallmach A, Grunert PC.

COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm

Navaeifar MR, Shahbaznejad L, Sadeghi Lotfabadi A, Rezai MS.

Utilization of Thromboelastogram and Inflammatory Markers in the Management of Hypercoagulable State in Patients with COVID-19 Requiring ECMO Support

Smolarz A, McCarthy P, Shmookler A, Badhwar V, Hayanga AJ, Sakhuja A.

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial

Arnardottir H, Pawelzik SC, Öhlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, Bäck M.

The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study

Tanacan A, Yazihan N, Erol SA, Anuk AT, Yucel Yetiskin FD, Biriken D, Ozgu-Erdinc AS, Keskin HL, Moraloglu Tekin O, Sahin D.

Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2 - methodology, key messages and justifying information

Schulze-Koops H, Krüger K, Hoyer BF, Leipe J, Iking-Konert C, Specker C; Commission for Pharmacotherapy and the Board of Directors of the German Society for Rheumatology.

Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease

Esteve-Sole A, Anton J, Pino-Ramírez RM, Sanchez-Manubens J, Fumadó V, Fortuny C, Rios-Barnes M, Sanchez-de-Toledo J, Girona-Alarcón M, Mosquera JM, Ricart S, Launes C, de Sevilla MF, Jou C, Muñoz-Almagro C, González-Roca E, Vergara A, Carrillo J, Juan M, Cuadras D, Noguera-Julian A, Jordan I, Alsina L.

Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study

Pitre T, Jones A, Su J, Helmeczi W, Xu G, Lee C, Shamsuddin A, Mir A, MacGregor S, Duong M, Ho T, Beauchamp MK, Costa AP, Kruisselbrink R; COREG Investigators.

Covidophobia: From Cytokine Storm to Mass Hysteria, a New Subtype of Hypochondriasis?

Gama Marques J, Madruga Dias J.

Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review

Cherqaoui B, Koné-Paut I, Yager H, Bourgeois FL, Piram M.

Immunomodulatory and anti-cytokine therapeutic potential of curcumin and its derivatives for treating COVID-19 - a computational modeling

Noor H, Ikram A, Rathinavel T, Kumarasamy S, Nasir Iqbal M, Bashir Z.

Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19

Amar J, Touront N, Ciron AM, Pendaries C.

Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?

Nagoor Meeran MF, Seenipandi A, Javed H, Sharma C, Hashiesh HM, Goyal SN, Jha NK, Ojha S.

The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus

Zheng M, Wang X, Guo H, Fan Y, Song Z, Lu Z, Wang J, Zheng C, Dong L, Ma Y, Zhu Y, Fang H, Ye S.

Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNetâ„¢ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses

Thangavel N, Al Bratty M, Al Hazmi HA, Najmi A, Ali Alaqi RO.

COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm

Botta C, Indrieri A, Garofalo E, Biamonte F, Bruni A, Pasqua P, Cesario F, Costanzo FS, Longhini F, Mendicino F.

Epigenetic Underpinnings of Inflammation: Connecting the dots between Pulmonary Diseases, Lung Cancer and COVID-19

Ahmad S, Manzoor S, Siddiqui S, Mariappan N, Zafar I, Ahmad A, Ahmad A.

Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population

Maconi G, Bosetti C, De Monti A, Boyapati RK, Shelton E, Piazza N, Carvalhas Gabrielli AM, Lenti MV, Bezzio C, Ricci C, Greco S, Romeo S, Giangregorio F, Gridavilla D, Tagliani F, Massari A, Pastorelli L, DiSabatino A, Saibeni S, Alicante S, Ferretti F, Rizzardini G, Galli M, Ardizzone S.

Vaping-Associated Lung Injury During COVID-19 Multisystem Inflammatory Syndrome Outbreak

Hassoun A, Brady K, Arefi R, Trifonova I, Tsirilakis K.

Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases

Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC, Sota J, Dinarello CA.

Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice

Karhadkar TR, Pilling D, Gomer RH.

Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2

Esposito S, Principi N.

Lessons of the month: A misunderstood teenager with paediatric inflammatory multisystem syndrome - temporarily associated with SARS-CoV-2 admitted under adult medicine

Patel ST, Wright H.

Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

Hasseli R, Mueller-Ladner U, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schäfer M, Schmeiser T, Strangfeld A, Schulze-Koops H, Voll RE, Specker C, Regierer AC.

Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'

Kermani TA.

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Wong AY, MacKenna B, Morton CE, Schultze A, Walker AJ, Bhaskaran K, Brown JP, Rentsch CT, Williamson E, Drysdale H, Croker R, Bacon S, Hulme W, Bates C, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson L, Mathur R, Wing K, Forbes H, Eggo RM, Parry J, Hester F, Harper S, Evans SJ, Smeeth L, Douglas IJ, Goldacre B; OpenSAFELY Collaborative.

Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection

Horspool AM, Kieffer T, Russ BP, DeJong MA, Wolf MA, Karakiozis JM, Hickey BJ, Fagone P, Tacker DH, Bevere JR, Martinez I, Barbier M, Perrotta PL, Damron FH.

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting

Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC; International Organization for the Study of Inflammatory Bowel Disease (IOIBD); International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).

Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic

Iborra I, Puig M, Marín L, Calafat M, Cañete F, Quiñones C, González-González L, Cardona G, Mañosa M, Domènech E.

Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation

Garcia MA, Barreras PV, Lewis A, Pinilla G, Sokoll LJ, Kickler T, Mostafa H, Caturegli M, Moghekar A, Fitzgerald KC, Pardo CA.

COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone

Sarma A, Christenson S, Mick E, Deiss T, DeVoe C, Pisco A, Ghale R, Jauregui A, Byrne A, Moazed F, Spottiswoode N, Sinha P, Zha B, Neff N, Tan M, Serpa PH, Ansel KM, Wilson J, Leligdowicz A, Seigel E, Sirota M, DeRisi J, Matthay M, Consortium C, Hendrickson C, Kangelaris K, Krummel M, Woodruff P, Erle D, Calfee C, Langelier C.

Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS)

García-Salido A, Antón J, David Martínez-Pajares J, Garcia GG, Cortés BG, Tagarro A; Grupo de trabajo de la Asociación Española de Pediatría para el Síndrome Inflamatorio Multisistémico Pediátrico vinculado a SARS-CoV-2.

Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland

Fouriki A, Fougère Y, De Camaret C, Blanchard Rohner G, Grazioli S, Wagner N, Relly C, Pachlopnik Schmid J, Trück J, Kottanatu L, Perez E, Perez MH, Schaffner D, Asner SA, Hofer M.

The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move

Hernández Ramírez V, López Serrano P.

Nucleocapsid and Spike Proteins of the Coronavirus SARS-CoV-2 Induce IL6 in Monocytes and Macrophages-Potential Implications for Cytokine Storm Syndrome

Karwaciak I, Sałkowska A, Karaś K, Dastych J, Ratajewski M.

Mitochondrial Functionality in Inflammatory Pathology-Modulatory Role of Physical Activity

Casuso RA, Huertas JR.

When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It

Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, Sicari F, Vernelli C, Di Giuli C, Andreani P, Mariottini A, Francucci M, Sensi E, Costantini M, Bruzzone P, D'Andrea V, Gioia S, Cirocchi R, Tiri B.

Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?

Kovalchuk A, Wang B, Li D, Rodriguez-Juarez R, Ilnytskyy S, Kovalchuk I, Kovalchuk O.

COVID-19-related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn

Khaund Borkotoky R, Banerjee Barua P, Paul SP, Heaton PA.

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics

Mason CY, Kanitkar T, Richardson CJ, Lanzman M, Stone Z, Mahungu T, Mack D, Wey EQ, Lamb L, Balakrishnan I, Pollara G.

Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury

Weckbach LT, Curta A, Bieber S, Kraechan A, Brado J, Hellmuth JC, Muenchhoff M, Scherer C, Schroeder I, Irlbeck M, Maurus S, Ricke J, Klingel K, Kääb S, Orban M, Massberg S, Hausleiter J, Grabmaier U.

COVID-19 Associated Multisystem Inflammatory Syndrome: A Systematic Review and Meta-analysis

Baradaran A, Malek A, Moazzen N, Abbasi Shaye Z.

COVID 19: in the eye of the cytokine storm

Liuzzo G, Patrono C.

ACEi reduces hypertension-induced hyperinflammation in COVID-19

Lim GB.

Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19

Liu Y, Tan W, Chen H, Zhu Y, Wan L, Jiang K, Guo Y, Tang K, Xie C, Yi H, Kuang Y, Luo Y.

Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19

Azmy V, Kaman K, Tang D, Zhao H, Dela Cruz C, Topal JE, Malinis M, Price CC.

Multisystem inflammatory syndrome in children related to COVID-19: An update regarding the presentation of two critically ill patients

Taffarel P, Jorro Barón F, Rodríguez AP, Widmer J, Meregallia C.

COVID-19-related cytokine and information storm: considerations regarding multisystem inflammatory syndrome in children

Katsicas MM.

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications

Dalakas MC.

A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional chinese medicines

Dai Y, Qiang W, Gui Y, Tan X, Pei T, Lin K, Cai S, Sun L, Ning G, Wang J, Guo H, Sun Y, Cheng J, Xie L, Lan X, Wang D.

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial

Rieder M, Schubach F, Schmoor C, von Spee-Mayer C, Wengenmayer T, Rilinger J, Staudacher D, Bode C, Duerschmied D, Supady A.

Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19

Sohrabi Y, Reinecke H, Godfrey R.

Immunomodulation using CONVEHY® for COVID-19: from the storm to the cytokine anticyclone

García-Hernández R, Espigares-López MI, Miralles-Aguiar F, Gámiz-Sánchez R, Arroyo Fernández FJ, Pernia Romero A, Torres LM, Calderón Seoane E; en nombre del GRUPO DE INVESTIGACIÓN CONVEHY.

Adherence of Infusible Biologics During the Time of COVID-19 Among Patients with Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study

Khan N, Yang YX.

Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients with Inflammatory Bowel Diseases: Results from an International Registry

Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD.

SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment

Abdel-Haq N, Asmar BI, Deza Leon MP, McGrath EJ, Arora HS, Cashen K, Tilford B, Charaf Eddine A, Sethuraman U, Ang JY.

COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation

Mehra B, Aggarwal V, Kumar P, Kundal M, Gupta D, Kumar A, Dugaya SK.

Intravenous Immunoglobulin may Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain-Barré Syndrome

Chakraborty N, Kumar H.

Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients' behavior

Dorfman L, Nassar R, Binjamin Ohana D, Oseran I, Matar M, Shamir R, Assa A.

Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages

Anil SM, Shalev N, Vinayaka AC, Nadarajan S, Namdar D, Belausov E, Shoval I, Mani KA, Mechrez G, Koltai H.

Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019

Kwak JH, Lee SY, Choi JW; Korean Society of Kawasaki Disease.

Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm

Pum A, Ennemoser M, Adage T, Kungl AJ.

Adverse effects of non-steroidal anti-inflammatory drugs in patients with viral respiratory infections: rapid systematic review

von Philipsborn P, Biallas R, Burns J, Drees S, Geffert K, Movsisyan A, Pfadenhauer LM, Sell K, Strahwald B, Stratil JM, Rehfuess E.

What Is a Cytokine Storm and Should It Matter to Me?

Simkin J, Strange T, Leblanc N, Rivera JC.

Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2

Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS.

Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical Illness

Wu J, Cyr A, Gruen D, Lovelace T, Benos P, Chen T, Guyette F, Yazer M, Daley B, Miller R, Harbrecht B, Claridge J, Phelan H, Zuckerbraun B, Neal M, Johansson P, Stensballe J, Namas R, Vodovotz Y, Sperry J, Billiar T, Group PS.

Inflammation and Vascular Injury as the Basis of COVID-19 Skin Changes: Preliminary Analysis of 23 Patients from the Literature

Zheng Y, Gong Z, Chen J, Lin Y, Liu Y.

Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection

Chen JS, Alfajaro MM, Chow RD, Wei J, Filler RB, Eisenbarth SC, Wilen CB.

On the role of bacterial metalloproteases in COVID-19 associated cytokine storm

Földvári-Nagy L, Schnabel T, Dörnyei G, Korcsmáros T, Lenti K.

Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis

Singh AK, Jena A, Kumar-M P, Jha DK, Sharma V.

Systemic Inflammatory Index Is a Novel Predictor of Intubation Requirement and Mortality after SARS-CoV-2 Infection

Muhammad S, Fischer I, Naderi S, Faghih Jouibari M, Abdolreza S, Karimialavijeh E, Aslzadeh S, Mashayekhi M, Zojaji M, Kahlert UD, Hänggi D.

Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients

Lavillegrand JR, Garnier M, Spaeth A, Mario N, Hariri G, Pilon A, Berti E, Fieux F, Thietart S, Urbina T, Turpin M, Darrivière L, Fartoukh M, Verdonk F, Dumas G, Tedgui A, Guidet B, Maury E, Chantran Y, Voiriot G, Ait-Oufella H.

[Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients]

Specker C; Ad-hoc-Kommission COVID-19 der DGRh, Schulze-Koops H; Vorstand der DGRh.

Childhood Multisystem Inflammatory Syndrome: An Emerging Disease with Prominent Cardiovascular Involvement-A Scoping Review

Malviya A, Mishra A.

Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19

Mishra K, Naffouj S, Gorgis S, Ibrahim H, Gill S, Fadel R, Chatfield A, Tang A, Salgia R.

COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment

Chen X, Yu C, Jing H, Wang C, Zhao X, Zhang J, Zhang S, Liu H, Xie R, Shi J.

Macrophage Activation and Cytokine Release Syndrome in COVID-19: Current Updates and Analysis of Repurposed and Investigational Anti-Cytokine Drugs

Iqubal A, Hoda F, Najmi AK, Haque SE.

Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19

Lev S, Gottesman T, Sahaf Levin G, Lederfein D, Berkov E, Diker D, Zaidman A, Nutman A, Ilan Ber T, Angel A, Kellerman L, Barash E, Navon R, Boico O, Israeli Y, Rosenberg M, Gelman A, Kalfon R, Simon E, Avni N, Hainrichson M, Zarchin O, Gottlieb TM, Oved K, Eden E, Tadmor B.

Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality

Balnis J, Adam AP, Chopra A, Chieng HC, Drake LA, Martino N, Bossardi Ramos R, Feustel PJ, Overmyer KA, Shishkova E, Coon JJ, Singer HA, Judson MA, Jaitovich A.

Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19

Patel VV, Felsen UR, Fisher M, Fazzari MJ, Ginsberg MS, Beil R, Akiyama MJ, Anastos K, Hanna DB.

Extracardiac imaging findings in COVID-19-associated multisystem inflammatory syndrome in children

Fenlon Iii EP, Chen S, Ruzal-Shapiro CB, Jaramillo D, Maddocks ABR.

Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19

Bandopadhyay P, Rozario R, Lahiri A, Sarif J, Ray Y, Paul SR, Roy R, Maiti R, Chaudhuri K, Bagchi S, Maiti A, Perwez MM, Sharma Sarkar B, Roy D, Chakraborty R, Vasudevan JS, Sharma S, Biswas D, Maiti C, Saha B, Bhattacharya P, Pandey R, Chatterjee S, Paul S, Ganguly D.

COVID-19 and inflammatory bowel disease: A pathophysiological assessment

Yang C, Xiao SY.

Persistent Post-COVID-19 Inflammatory Interstitial Lung Disease: An Observational Study of Corticosteroid Treatment

Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, Preston R, Thillai M, Dewar A, Molyneaux PL, West AG.

Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis

Sood M, Sharma S, Sood I, Sharma K, Kaushik A.

Neutrophil Extracellular Traps and Their Implications in Cardiovascular and Inflammatory Disease

Klopf J, Brostjan C, Eilenberg W, Neumayer C.

The Covid-19 Arterial Thromboembolic Complications: From Inflammation To Immunothrombosis Through Anti-Phospholipid Autoantibodies

Roncati L, Manenti A, Manco G, Farinetti A, Mattioli A.

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions

Ungaro RC, Kappelman MD, Rubin DT, Colombel JF.

Multisystem Inflammatory Syndrome in Children: Clinical Features and Management-Intensive Care Experience from a Pediatric Public Hospital in Western India

Shobhavat L, Solomon R, Rao S, Bhagat I, Prabhu S, Prabhu S, Chandrakar M, Bodhanwala M.

Multisystem Inflammatory Syndrome of Children Related to SARS-CoV-2: A Novel Experience in Children with a Novel Virus

Bhattacharyya P.

Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms

Huang X, Hussain B, Chang J.

Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China

Yang KB, Feng H, Zhang H.

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

Favalli EG, Bugatti S, Klersy C, Biggioggero M, Rossi S, De Lucia O, Bobbio-Pallavicini F, Murgo A, Balduzzi S, Caporali R, Montecucco C.

A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients

Ringer M, Azmy V, Kaman K, Tang D, Cheung H, Azar MM, Price C, Malinis M.

Complexities of the COVID-19 vaccine and multisystem inflammatory syndrome in children

Blumenthal JA, Burns JP.

Severe acute respiratory syndrome coronavirus 2-induced multisystem inflammatory syndrome in children

Feng Z, Bao Y, Yang Y, Zheng Y, Shen K.

Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Vanassche T, Engelen MM, Van Thillo Q, Wauters J, Gunst J, Wouters C, Vandenbriele C, Rex S, Liesenborghs L, Wilmer A, Meersseman P, Van den Berghe G, Dauwe D, Verbeke G, Thomeer M, Fivez T, Mesotten D, Ruttens D, Heytens L, Dapper I, Tuyls S, De Tavernier B, Verhamme P; DAWn consortium members.

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19

Timpani CA, Rybalka E.

Disturbances of the hemostasis system and expression of inflammatory reaction in patients with new coronaviral pneumonia

Presnyakova MV, Galova EA, Sosnina LN, Popovicheva AN, Lyubavina NA, Kostina OV, Kuznetsova VL, Karyakin NN.

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species

Moustaqil M, Ollivier E, Chiu HP, Van Tol S, Rudolffi-Soto P, Stevens C, Bhumkar A, Hunter DJB, Freiberg AN, Jacques D, Lee B, Sierecki E, Gambin Y.

Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old

Schwartz SP, Walker TC, Kihlstrom M, Isani M, Smith MM, Smith RL, McLean SE, Clement KC, Phillips MR.

ADHERENCE TO INTRAVENOUS BIOLOGICAL TREATMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC

SuÁrez Ferrer C, Perez Robles T, Martin-Arranz MD.

Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results

Fernández Álvarez P, Belvis Jiménez M, Maldonado Pérez B, Castro Laria L, Caunedo Álvarez Á, Rodríguez de Los Ríos JL, Argüelles-Arias F.

Effects of Prone Ventilation on Oxygenation, Inflammation, and Lung Infiltrates in COVID-19 Related Acute Respiratory Distress Syndrome: A Retrospective Cohort Study

Khullar R, Shah S, Singh G, Bae J, Gattu R, Jain S, Green J, Anandarangam T, Cohen M, Madan N, Prasanna P.

Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark

Cordtz R, Lindhardsen J, Soussi BG, Vela J, Uhrenholt L, Westermann R, Kristensen S, Nielsen H, Torp-Pedersen C, Dreyer L.

Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey

Mahil SK, Yates M, Langan SM, Yiu ZZN, Tsakok T, Dand N, Mason KJ, McAteer H, Meynell F, Coker B, Vincent A, Urmston D, Vesty A, Kelly J, Lancelot C, Moorhead L, Bachelez H, Bruce IN, Capon F, Contreras CR, Cope AP, De La Cruz C, Di Meglio P, Gisondi P, Hyrich K, Jullien D, Lambert J, Marzo-Ortega H, McKinnes I, Naldi L, Norton S, Puig L, Sengupta R, Spuls P, Torres T, Warren RB, Waweru H, Weinman J, Griffiths CM, Barker JN, Brown MA, Galloway JB, Smith CH.

Severe Acute Respiratory Syndrome Coronavirus 2 Placental Infection and Inflammation Leading to Fetal Distress and Neonatal Multi-Organ Failure in an Asymptomatic Woman

Schoenmakers S, Snijder P, Verdijk RM, Kuiken T, Kamphuis SSM, Koopman LP, Krasemann TB, Rousian M, Broekhuizen M, Steegers EAP, Koopmans MPG, Fraaij PLA, Reiss IKM.

Treatment of cytokine storm syndrome with IL-1 receptor antagonist anakinra in a patient with ARDS caused by COVID-19 infection: A case report

Kaps L, Labenz C, Grimm D, Schwarting A, Galle PR, Schreiner O.

Plasma exchange for COVID-19 thrombo-inflammatory disease

Arulkumaran N, Thomas M, Brealey D, Alwan F, Singh D, Lunn M, Welch A, Clark S, Raith E, Reddy U, Low R, Leverett D, Singer M, Scully M.

The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System

Ellison-Hughes GM, Colley L, O'Brien KA, Roberts KA, Agbaedeng TA, Ross MD.

Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway

Ort M, Dingemanse J, van den Anker J, Kaufmann P.

A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection

Ahmed F.

Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm

Desjarlais M, Wirth M, Lahaie I, Ruknudin P, Hardy P, Rivard A, Chemtob S.

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19

Trump S, Lukassen S, Anker MS, Chua RL, Liebig J, Thürmann L, Corman VM, Binder M, Loske J, Klasa C, Krieger T, Hennig BP, Messingschlager M, Pott F, Kazmierski J, Twardziok S, Albrecht JP, Eils J, Hadzibegovic S, Lena A, Heidecker B, Bürgel T, Steinfeldt J, Goffinet C, Kurth F, Witzenrath M, Völker MT, Müller SD, Liebert UG, Ishaque N, Kaderali L, Sander LE, Drosten C, Laudi S, Eils R, Conrad C, Landmesser U, Lehmann I.

Cytokine release syndrome: inhibition of pro-inflammatory cytokines as a solution for reducing COVID-19 mortality

Moradian N, Gouravani M, Salehi MA, Heidari A, Shafeghat M, Hamblin MR, Rezaei N.

Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?

Amaral-Machado L, Oliveira WN, Rodrigues VM, Albuquerque NA, Alencar ÉN, Egito EST.

Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations

Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, Souayah N.

Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients

Kloc M, Ghobrial RM, Lipińska-Opałka A, Wawrzyniak A, Zdanowski R, Kalicki B, Kubiak JZ.

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator

Mussini C, Cozzi-Lepri A, Menozzi M, Meschiari M, Franceschini E, Rogati C, Cuomo G, Bedini A, Iadisernia V, Volpi S, Milic J, Tonelli R, Brugioni L, Pietrangelo A, Girardis M, Cossarizza A, Clini E, Guaraldi G; Modena Covid‐19 Working Group (MoCo19); Office of information and communication technologies of Policlinico di Modena.

A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications

McCarthy CG, Wilczynski S, Wenceslau CF, Webb RC.

Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications

Hirawat R, Saifi MA, Godugu C.

Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury

Bime C, Casanova NG, Nikolich-Zugich J, Knox KS, Camp SM, Garcia JGN.

Electrocardiographic changes in children with multisystem inflammation associated with COVID-19

Regan W, O'Byrne L, Stewart K, Miller O, Pushparajah K, Theocharis P, Wong J, Rosenthal E.

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, Malekmohammad M, Mortazavi SM, Khoundabi B, Mansouri D, Moniri A, Hajifathali A, Roshandel E, Mortaz E, Adcock IM.

[Improving parasympathetic functioning to contain the inflammatory response of COVID-19 infection]

Ferrer MH, Severin R, Lefort H, Jacob S, Trousselard M.

Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19

Argañaraz GA, Palmeira JDF, Argañaraz ER.

Heart failure and COVID-19: synergism of two inflammatory conditions?

Khan E.

Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19

Xiang D, Ren X, Chen Q, Yu H, Li X, Liu D.

Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'

Aydin SZ, Hepworth E, Tugwell P.

Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin et al

Freites Nuñez DD, Leon L, Mucientes A, Rodriguez-Rodriguez L, Font Urgelles J, Madrid García A, Colomer JI, Jover JA, Fernandez-Gutierrez B, Abasolo L.

Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting real-world data from a multicenter observational study targeting inflammatory and infectious dermatoses

Gironi LC, Damiani G, Zavattaro E, Pacifico A, Santus P, Pigatto PDM, Cremona O, Savoia P.

The Perfect Storm: Hidden Risk of Child Maltreatment During the Covid-19 Pandemic

Rodriguez CM, Lee SJ, Ward KP, Pu DF.

Vascular Endothelial Glycocalyx Damage in COVID-19

Yamaoka-Tojo M.

COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease

Fernandez-Ruiz R, Paredes JL, Niewold TB.

Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted Patients

Mohamed IH, Chowdary PB, Shetty S, Sammartino C, Sivaprakasam R, Lindsey B, Thuraisingham R, Yaqoob MM, Khurram MA.

Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases

Iliev ID, Cadwell K.

Thrombophilia in Pediatric Patients with Multisystem Inflammatory Syndrome in Children Secondary to Coronavirus Disease 2019 Supported on Extracorporeal Membrane Oxygenation

Minen F, Hands C, Mustafa MR, Pienaar A, Lillie J.

Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia

Pagano G, Manfredi C, Pallardó FV, Lyakhovich A, Tiano L, Trifuoggi M.

Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic

Schvartz A, Belot A, Kone-Paut I.

COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps

Borges L, Pithon-Curi TC, Curi R, Hatanaka E.

Anti-inflammatory substances from onions could be an option for treatment of COVID-19 - a hypothesis

Dorsch W, Ring J.

Consequences and management of COVID-19 on the care activity of an inflammatory Bowel Disease unit

El Hajra I, Calvo M, Santos Pérez E, Blanco Rey S, González Partida I, Matallana V, González-Lama Y, Vera MI.

Delayed diffuse inflammatory myocardial damage in a child with a history of systemic inflammatory syndrome related to COVID-19

Mahdavi M, Houshmand G, Pouraliakbar H, Mortaz Hejri G.

Hyperinflammation and Immune Response Generation in COVID-19

Mishra KP, Singh AK, Singh SB.

Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm

García-Meniño I, Forcelledo L, Rosete Y, García-Prieto E, Escudero D, Fernández J.

Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer's disease in COVID-19 patients

Wang H, Qin R, Zhang J, Chen Y.

COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report

Tiwari L, Shekhar S, Bansal A, Kumar S.